The University of Chicago Header Logo

Michael H. Davidson

TitleClinical Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Cardiology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kastelein JJP, Hsieh A, Dicklin MR, Ditmarsch M, Davidson MH. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments. Curr Atheroscler Rep. 2024 Feb; 26(2):35-44. PMID: 38133847; PMCID: PMC10838241.
      Citations: 1     Fields:    Translation:Humans
    2. Ballantyne CM, Ditmarsch M, Kastelein JJ, Nelson AJ, Kling D, Hsieh A, Curcio DL, Maki KC, Davidson MH, Nicholls SJ. Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial. J Clin Lipidol. 2023 Jul-Aug; 17(4):491-503. PMID: 37277261.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    3. Martin SS, Ditmarsch M, Simmons M, Alp N, Turner T, Davidson MH, Kastelein JJP. Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition. Eur Heart J Cardiovasc Pharmacother. 2023 02 02; 9(2):148-155. PMID: 36307922; PMCID: PMC9892865.
      Citations: 1     Fields:    Translation:Humans
    4. Nicholls SJ, Ditmarsch M, Kastelein JJ, Rigby SP, Kling D, Curcio DL, Alp NJ, Davidson MH. Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial. Nat Med. 2022 08; 28(8):1672-1678. PMID: 35953719.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    5. Wilson PWF, Jacobson TA, Martin SS, Jackson EJ, Le NA, Davidson MH, Vesper HW, Frikke-Schmidt R, Ballantyne CM, Remaley AT. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group. J Clin Lipidol. 2021 Sep-Oct; 15(5):629-648. PMID: 34802986.
      Citations: 23     Fields:    Translation:Humans
    6. Weiser M, Zamora D, Levi L, Nastas I, Gonen I, Radu P, Matei V, Nacu A, Boronin L, Davidson M, Davis JM. Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials. Schizophr Bull. 2021 07 08; 47(4):1077-1087. PMID: 33479775; PMCID: PMC8266648.
      Citations: 8     Fields:    Translation:Humans
    7. Pulipati VP, Davidson MH. The clinical black, white, and gray lessons. Curr Opin Lipidol. 2021 04 01; 32(2):151-156. PMID: 33651748.
      Citations: 1     Fields:    Translation:Humans
    8. Pulipati VP, Davidson MH. How I treat statin-associated side effects in an outpatient setting. Future Cardiol. 2021 10; 17(7):1249-1260. PMID: 33464124.
      Citations: 4     Fields:    Translation:Humans
    9. Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, McGuire DK, Mozaffarian D, Ridker PM, Ray KK, Katona BG, Himmelmann A, Loss LE, Rensfeldt M, Agrawal R, Menon V, Wolski K, Nissen SE, Koenig W, Lundström T. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA. 2020 12 08; 324(22):2268-2280. PMID: 33190147; PMCID: PMC7667577.
      Citations: 206     Fields:    Translation:Humans
    10. Pergola PE, Devalaraja M, Fishbane S, Chonchol M, Mathur VS, Smith MT, Lo L, Herzog K, Kakkar R, Davidson MH. Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. J Am Soc Nephrol. 2021 01; 32(1):211-222. PMID: 33272965; PMCID: PMC7894678.
      Citations: 24     Fields:    Translation:Humans
    11. Handelsman Y, Jellinger PS, Guerin CK, Bloomgarden ZT, Brinton EA, Budoff MJ, Davidson MH, Einhorn D, Fazio S, Fonseca VA, Garber AJ, Grunberger G, Krauss RM, Mechanick JI, Rosenblit PD, Smith DA, Wyne KL. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary. Endocr Pract. 2020 Oct; 26(10):1196-1224. PMID: 33471721.
      Citations: 49     Fields:    Translation:Humans
    12. Pulipati VP, Davidson MH. Recent advances and emerging therapies in management of dyslipidemias. Trends Cardiovasc Med. 2021 10; 31(7):419-424. PMID: 32858149.
      Citations: 1     Fields:    Translation:Humans
    13. Moriarty PM, Gorby LK, Stroes ES, Kastelein JP, Davidson M, Tsimikas S. Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis. Curr Atheroscler Rep. 2020 07 25; 22(9):48. PMID: 32710255; PMCID: PMC7381416.
      Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
    14. Dunbar RL, Davidson M, Rensfeldt M, Yang H, Nilsson C, Oscarsson J, Gaudet D, Kvarnström M. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids Health Dis. 2020 May 30; 19(1):117. PMID: 32473640; PMCID: PMC7260759.
      Citations:    Fields:    Translation:Humans
    15. Davidson MH. Reducing residual cardiovascular risk with novel therapies. Curr Opin Lipidol. 2020 04; 31(2):108-110. PMID: 32132416.
      Citations:    Fields:    Translation:Humans
    16. Wolska A, Lo L, Sviridov DO, Pourmousa M, Pryor M, Ghosh SS, Kakkar R, Davidson M, Wilson S, Pastor RW, Goldberg IJ, Basu D, Drake SK, Cougnoux A, Wu MJ, Neher SB, Freeman LA, Tang J, Amar M, Devalaraja M, Remaley AT. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides. Sci Transl Med. 2020 01 29; 12(528). PMID: 31996466; PMCID: PMC8359806.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    17. Davidson M. The Battle of the HDL Subfractions. Cardiovasc Revasc Med. 2019 11; 20(11):943-944. PMID: 31865981.
      Citations:    Fields:    Translation:Humans
    18. Weiser M, Levi L, Zamora D, Biegon A, SanGiovanni JP, Davidson M, Burshtein S, Gonen I, Radu P, Slobozean Pavalache K, Nastas I, Hemi R, Ryan T, Davis JM. Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial. JAMA Psychiatry. 2019 10 01; 76(10):1009-1017. PMID: 31365044; PMCID: PMC6669788.
      Citations: 10     Fields:    Translation:Humans
    19. Davidson M, Wagner AD, Kouvelakis K, Nanji H, Starling N, Chau I, Watkins D, Rao S, Peckitt C, Cunningham D. Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials. Eur J Cancer. 2019 11; 121:40-47. PMID: 31542640.
      Citations: 28     Fields:    Translation:Humans
    20. Toth PP, Bays HE, Brown WV, Catapano AL, Davidson MH, Tomassini JE, Jensen E, Polis AB, Tershakovec AM, Farnier M. Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy. J Clin Lipidol. 2019 Nov - Dec; 13(6):997-1007.e8. PMID: 31629703.
      Citations: 2     Fields:    Translation:Humans
    21. Rabinowitz J, Badescu S, Palamarchuk P, Filyk V, Voloshchuk A, Rud V, Melnyk E, Skrypnikov A, Davidson M, Saoud J, Luthringer R. Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial. Schizophr Res. 2019 09; 211:103-104. PMID: 31375316.
      Citations: 4     Fields:    Translation:Humans
    22. Vallejo-Vaz AJ, Ray KK, Ginsberg HN, Davidson MH, Eckel RH, Lee LV, Bessac L, Pordy R, Letierce A, Cannon CP. Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control. Atherosclerosis. 2019 09; 288:85-93. PMID: 31349086.
      Citations: 12     Fields:    Translation:HumansCells
    23. Ray KK, Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Louie MJ, Bujas-Bobanovic M, Minini P, Eckel RH, Cannon CP. Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials. Atherosclerosis. 2019 09; 288:194-202. PMID: 31253441.
      Citations: 23     Fields:    Translation:HumansCells
    24. Reichenberg A, Velthorst E, Davidson M. Cognitive impairment and psychosis in schizophrenia: independent or linked conditions? World Psychiatry. 2019 Jun; 18(2):162-163. PMID: 31059615; PMCID: PMC6502409.
      Citations: 16     
    25. Roy S, Loblaw A, Cheung P, Chu W, Chung HT, Vesprini D, Ong A, Chowdhury A, Panjwani D, Pang G, Korol R, Davidson M, Ravi A, McCurdy B, Helou J, Zhang L, Mamedov A, Deabreu A, Quon HC. Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials. Clin Oncol (R Coll Radiol). 2019 09; 31(9):621-629. PMID: 31126725.
      Citations: 2     Fields:    Translation:Humans
    26. Benes LB, Brummell K, Roth M, Shen L, Davidson MH. The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature. Cardiovasc Revasc Med. 2020 02; 21(2):200-204. PMID: 31153847.
      Citations:    Fields:    Translation:Humans
    27. Weiser M, Levi L, Burshtein S, Cirjaliu D, Gonen I, Yolken R, Davidson M, Zamora D, Davis JM, Chiri?a R. The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial. Schizophr Res. 2019 04; 206:325-332. PMID: 30455075.
      Citations: 17     Fields:    Translation:Humans
    28. Maki KC, Eren F, Cassens ME, Dicklin MR, Davidson MH. ?-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps. Adv Nutr. 2018 Nov 01; 9(6):688-700. PMID: 30184091; PMCID: PMC6247292.
      Citations: 25     Fields:    Translation:Humans
    29. Benes LB, Brandt DJ, Brandt EJ, Davidson MH. How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention. Curr Cardiol Rep. 2018 10 17; 20(12):138. PMID: 30328514.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    30. Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Wolski K, Nissen SE, Koenig W, Karlson BW, Lundström T. Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. Clin Cardiol. 2018 Oct; 41(10):1281-1288. PMID: 30125052; PMCID: PMC6489732.
      Citations: 57     Fields:    Translation:Humans
    31. Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Eckel RH, Cannon CP, Lee LV, Bessac L, Pordy R, Letierce A, Ray KK. Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. J Am Heart Assoc. 2018 09 18; 7(18):e009221. PMID: 30371190; PMCID: PMC6222947.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    32. Mansukhani S, Barber LJ, Kleftogiannis D, Moorcraft SY, Davidson M, Woolston A, Proszek PZ, Griffiths B, Fenwick K, Herman B, Matthews N, O'Leary B, Hulkki S, Gonzalez De Castro D, Patel A, Wotherspoon A, Okachi A, Rana I, Begum R, Davies MN, Powles T, von Loga K, Hubank M, Turner N, Watkins D, Chau I, Cunningham D, Lise S, Starling N, Gerlinger M. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing. Clin Chem. 2018 11; 64(11):1626-1635. PMID: 30150316; PMCID: PMC6214522.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    33. Brandt EJ, Benes LB, Lee L, Dayspring TD, Sorrentino M, Davidson M. The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients. J Cardiovasc Pharmacol Ther. 2019 01; 24(1):54-61. PMID: 29940784.
      Citations: 1     Fields:    Translation:Humans
    34. Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R, Patsopoulos NA, Ripke S, Wei Z, Yu D, Lee PH, Turley P, Grenier-Boley B, Chouraki V, Kamatani Y, Berr C, Letenneur L, Hannequin D, Amouyel P, Vardarajan BN, Reitz C, Goate AM, Huentelman MJ, Kamboh MI, Larson EB, Rogaeva E, St George-Hyslop P, Hakonarson H, Kukull WA, Farrer LA, Barnes LL, Beach TG, Demirci FY, Head E, Hulette CM, Jicha GA, Kauwe JSK, Kaye JA, Leverenz JB, Levey AI, Lieberman AP, Pankratz VS, Poon WW, Quinn JF, Saykin AJ, Schneider LS, Smith AG, Sonnen JA, Stern RA, Van Deerlin VM, Van Eldik LJ, Harold D, Russo G, Rubinsztein DC, Bayer A, Tsolaki M, Proitsi P, Fox NC, Owen MJ, Mead S, Passmore P, Morgan K, Rossor M, Lupton MK, Hoffmann P, Lawlor B, McQuillin A, Al-Chalabi A, Bis JC, Seshadri S, Beiser A, Rice K, van der Lee SJ, De Jager PL, Geschwind DH, Riemenschneider M, Riedel-Heller S, Rotter JI, Ransmayr G, Hyman BT, Cruchaga C, Winsvold B, Palta P, Farh KH, Cuenca-Leon E, Furlotte N, Ligthart L, Terwindt GM, Freilinger T, Ran C, Gordon SD, Borck G, Adams HHH, Wedenoja J, Buring JE, Hrafnsdottir M, Hottenga JJ, Penninx B, Artto V, Kaunisto M, Martin NG, Montgomery GW, Kurki MI, Huang H, Huang J, Sandor C, Webber C, Muller-Myhsok B, Schreiber S, Salomaa V, Loehrer E, Macaya A, Pozo-Rosich P, Hansen T, Werge T, Kaprio J, Metspalu A, Kubisch C, Ferrari MD, Belin AC, van den Maagdenberg AMJM, Zwart JA, Boomsma D, Eriksson N, Olesen J, Chasman DI, Nyholt DR, Avbersek A, Baum L, Berkovic S, Bradfield J, Buono RJ, Catarino CB, De Jonghe P, Dlugos D, Ferraro TN, French J, Hjalgrim H, Jamnadas-Khoda J, Kunz WS, Lerche H, Leu C, Lindhout D, Lo W, Lowenstein D, McCormack M, Molloy A, Ng PW, Oliver K, Privitera M, Radtke R, Ruppert AK, Sander T, Schachter S, Schankin C, Scheffer I, Schoch S, Sisodiya SM, Smith P, Sperling M, Striano P, Surges R, Thomas GN, Visscher F, Whelan CD, Zara F, Heinzen EL, Marson A, Becker F, Stroink H, Zimprich F, Gibbs R, Martinez M, Morris HR, Sharma M, Ryten M, Mok KY, Pulit S, Bevan S, Holliday E, Attia J, Battey T, Boncoraglio G, Thijs V, Chen WM, Mitchell B, Rothwell P, Sharma P, Sudlow C, Markus H, Kourkoulis C, Raffeld M, Silliman S, Boraska Perica V, Thornton LM, Huckins LM, William Rayner N, Lewis CM, Gratacos M, Rybakowski F, Keski-Rahkonen A, Raevuori A, Hudson JI, Reichborn-Kjennerud T, Monteleone P, Karwautz A, Mannik K, Baker JH, O'Toole JK, Trace SE, Davis OSP, Helder SG, Herpertz-Dahlmann B, Danner UN, van Elburg AA, Clementi M, Forzan M, Lissowska J, Hauser J, Tortorella A, Maj M, Gonidakis F, Tziouvas K, Papezova H, Yilmaz Z, Wagner G, Cohen-Woods S, Herms S, Dick DM, Ripatti S, Andreassen OA, Espeseth T, Lundervold AJ, Steen VM, Pinto D, Scherer SW, Aschauer H, Schosser A, Alfredsson L, Padyukov L, Halmi KA, Mitchell J, Strober M, Bergen AW, Kaye W, Szatkiewicz JP, Ramos-Quiroga JA, Haavik J, Zayats T, Johansson S, Williams N, Dempfle A, Rothenberger A, Kuntsi J, Oades RD, Banaschewski T, Franke B, Buitelaar JK, Arias Vasquez A, Doyle AE, Reif A, Lesch KP, Freitag C, Rivero O, Palmason H, Romanos M, Langley K, Rietschel M, Witt SH, Dalsgaard S, Waldman I, Wilmot B, Molly N, Crosbie J, Schachar R, Loo SK, McGough JJ, Medland SE, Robinson E, Weiss LA, Bacchelli E, Bailey A, Bal V, Battaglia A, Bolton P, Cantor R, Dawson G, De Rubeis S, Green A, Klauck SM, Levitt P, Maestrini E, Mane S, De-Luca DM, Parr J, Regan R, Reichenberg A, Sandin S, Vorstman J, Wassink T, Wijsman E, Cook E, Santangelo S, Delorme R, Magalhaes T, Arking D, Schulze TG, Thompson RC, Strohmaier J, Matthews K, Melle I, Morris D, Blackwood D, McIntosh A, Bergen SE, Schalling M, Maaser A, Fischer SB, Fullerton JM, Mayoral F, Schofield PR, Cichon S, Degenhardt F, Schumacher J, Mitchell PB, Gershon ES, Rice J, Potash JB, Zandi PP, Craddock N, Ferrier IN, Alda M, Ophoff R, Pato C, Anjorin A, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018 06 22; 360(6395). PMID: 29930110; PMCID: PMC6097237.
      Citations: 685     Fields:    Translation:Humans
    35. Davidson M, Cafferkey C, Goode EF, Kouvelakis K, Hughes D, Reguera P, Kalaitzaki E, Peckitt C, Rao S, Watkins D, Chau I, Cunningham D, Starling N. Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients. Clin Colorectal Cancer. 2018 09; 17(3):223-230. PMID: 29980492.
      Citations: 19     Fields:    Translation:Humans
    36. Davidson MH. Clinical trials. Curr Opin Lipidol. 2018 06; 29(3):277-278. PMID: 29715246.
      Citations:    Fields:    Translation:Humans
    37. Keefe RSE, Harvey PD, Khan A, Saoud JB, Staner C, Davidson M, Luthringer R. Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial. J Clin Psychiatry. 2018 May/Jun; 79(3). PMID: 29873956.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    38. Davidson M, Stevenson M, Hsieh A, Ahmad Z, Roeters van Lennep J, Crowson C, Witztum JL. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study. J Clin Lipidol. 2018 Jul - Aug; 12(4):898-907.e2. PMID: 29784572.
      Citations: 23     Fields:    Translation:Humans
    39. White WB, Kloner RA, Angiolillo DJ, Davidson MH. Cardiorenal Safety of OTC Analgesics. J Cardiovasc Pharmacol Ther. 2018 03; 23(2):103-118. PMID: 29421936; PMCID: PMC5808827.
      Citations: 6     Fields:    Translation:Humans
    40. Benes LB, Bassi NS, Kalot MA, Davidson MH. Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia. Cardiol Clin. 2018 May; 36(2):277-285. PMID: 29609757.
      Citations: 1     Fields:    Translation:Humans
    41. Davidson MH. Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C. Eur Heart J. 2018 02 14; 39(7):620-622. PMID: 29342252.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    42. McCullough PA, Ballantyne CM, Sanganalmath SK, Langslet G, Baum SJ, Shah PK, Koren A, Mandel J, Davidson MH. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials). Am J Cardiol. 2018 04 15; 121(8):940-948. PMID: 29472008.
      Citations: 4     Fields:    Translation:Humans
    43. Robinson JG, Davidson MH. Can We Cure Atherosclerosis? Rev Cardiovasc Med. 2018; 19(S1):S20-S24. PMID: 30207554.
      Citations: 5     Fields:    Translation:Humans
    44. Roth EM, Davidson MH. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety. Rev Cardiovasc Med. 2018; 19(S1):S31-S46. PMID: 30207556.
      Citations: 16     Fields:    Translation:HumansAnimals
    45. Kirkpatrick B, Saoud JB, Strauss GP, Ahmed AO, Tatsumi K, Opler M, Luthringer R, Davidson M. The brief negative symptom scale (BNSS): Sensitivity to treatment effects. Schizophr Res. 2018 07; 197:269-273. PMID: 29275856.
      Citations: 9     Fields:    Translation:Humans
    46. Livny A, Reichenberg A, Fruchter E, Yoffe R, Goldberg S, Fenchel D, Burshtein S, Bachar E, Davidson M, Weiser M. A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis. Am J Psychiatry. 2018 04 01; 175(4):351-358. PMID: 29179579.
      Citations: 4     Fields:    Translation:Humans
    47. Stroes ESG, Susekov AV, de Bruin TWA, Davidson MH, Kvarnström M, Yang H. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. J Clin Lipidol. 2018 Mar - Apr; 12(2):321-330. PMID: 29289538.
      Citations: 7     Fields:    Translation:Humans
    48. Offman E, Davidson M, Abu-Rashid M, Chai P, Nilsson C. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers. Eur J Drug Metab Pharmacokinet. 2017 Oct; 42(5):815-825. PMID: 28116646.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    49. Davidson M, Saoud J, Staner C, Noel N, Luthringer E, Werner S, Reilly J, Schaffhauser JY, Rabinowitz J, Weiser M, Luthringer R. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. Am J Psychiatry. 2017 12 01; 174(12):1195-1202. PMID: 28750582.
      Citations: 27     Fields:    Translation:Humans
    50. Jacobson TA, Edelman SV, Galipeau N, Shields AL, Mallya UG, Koren A, Davidson MH. Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©. Patient. 2017 06; 10(3):321-334. PMID: 27981439; PMCID: PMC5422451.
      Citations: 6     Fields:    Translation:Humans
    51. Offman E, Davidson M, Nilsson C. No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers. Am J Cardiovasc Drugs. 2017 Jun; 17(3):251-260. PMID: 28197979.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    52. Offman E, Davidson M, Nilsson C. Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers. J Clin Lipidol. 2017 May - Jun; 11(3):739-748. PMID: 28506390.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    53. Davidson M, Stevenson M, Hsieh A, Ahmad Z, Crowson C, Witztum JL. The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study. Expert Rev Cardiovasc Ther. 2017 May; 15(5):415-423. PMID: 28338353.
      Citations: 14     Fields:    Translation:Humans
    54. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. Endocr Pract. 2017 Apr; 23(Suppl 2):1-87. PMID: 28437620.
      Citations: 312     Fields:    Translation:Humans
    55. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M, Zangeneh F, Bush MA. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com. Endocr Pract. 2017 Apr 02; 23(4):479-497. PMID: 28156151.
      Citations: 60     Fields:    Translation:HumansPHPublic Health
    56. Benes LB, Bassi NS, Davidson MH. Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia. Vasc Health Risk Manag. 2016; 12:481-490. PMID: 28003756; PMCID: PMC5161399.
      Citations: 5     Fields:    Translation:Humans
    57. Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2017 Mar 01; 174(3):216-229. PMID: 27919182; PMCID: PMC6231547.
      Citations: 314     Fields:    Translation:Humans
    58. Davidson MH, Benes LB. The future of n-3 polyunsaturated fatty acid therapy. Curr Opin Lipidol. 2016 12; 27(6):570-578. PMID: 27798489.
      Citations: 5     Fields:    Translation:Humans
    59. Ray KK, Ginsberg HN, Davidson MH, Pordy R, Bessac L, Minini P, Eckel RH, Cannon CP. Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Circulation. 2016 Dec 13; 134(24):1931-1943. PMID: 27777279; PMCID: PMC5147039.
      Citations: 43     Fields:    Translation:Humans
    60. Davidson DJ, Davidson MH. Using Discordance in Monozygotic Twins to Understand Causality of Cardiovascular Disease Risk Factors. JAMA Intern Med. 2016 10 01; 176(10):1530. PMID: 27479357.
      Citations:    Fields:    Translation:Humans
    61. Davidson MH. Intensive statin therapy in India: Demonstrating efficacy and safety. Indian Heart J. 2016 Nov - Dec; 68(6):756-757. PMID: 27931540; PMCID: PMC5143818.
      Citations:    Fields:    Translation:Humans
    62. Morton AM, Furtado JD, Lee J, Amerine W, Davidson MH, Sacks FM. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. J Clin Lipidol. 2016 Nov - Dec; 10(6):1442-1451.e4. PMID: 27919362.
      Citations: 9     Fields:    Translation:Humans
    63. Benes LB, Bassi NS, Davidson MH. The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter? Prog Cardiovasc Dis. 2016 Sep - Oct; 59(2):145-152. PMID: 27503844.
      Citations: 10     Fields:    Translation:Humans
    64. Maki KC, Guyton JR, Orringer CE, Hamilton-Craig I, Alexander DD, Davidson MH. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia. J Clin Lipidol. 2016 Jul-Aug; 10(4):905-914. PMID: 27578122.
      Citations: 18     Fields:    Translation:Humans
    65. Levi L, Werbeloff N, Pugachova I, Yoffe R, Large M, Davidson M, Weiser M. Has deinstitutionalization affected inpatient suicide? Psychiatric inpatient suicide rates between 1990 and 2013 in Israel. Schizophr Res. 2016 May; 173(1-2):75-8. PMID: 26965744.
      Citations: 4     Fields:    Translation:Humans
    66. Prentice-Mott HV, Meroz Y, Carlson A, Levine MA, Davidson MW, Irimia D, Charras GT, Mahadevan L, Shah JV. Directional memory arises from long-lived cytoskeletal asymmetries in polarized chemotactic cells. Proc Natl Acad Sci U S A. 2016 Feb 02; 113(5):1267-72. PMID: 26764383; PMCID: PMC4747767.
      Citations: 32     Fields:    Translation:HumansCells
    67. Velthorst E, Reichenberg A, Kapra O, Goldberg S, Fromer M, Fruchter E, Ginat K, de Haan L, Davidson M, Weiser M. Developmental Trajectories of Impaired Community Functioning in Schizophrenia. JAMA Psychiatry. 2016 Jan; 73(1):48-55. PMID: 26605520.
      Citations: 13     Fields:    Translation:Humans
    68. Singh A, Davidson M. Update on PCSK9 therapies for the treatment of dyslipidemia. Expert Rev Endocrinol Metab. 2016 Jan; 11(1):87-95. PMID: 30063452.
      Citations: 1     Fields:    
    69. Davidson MH, Tomassini JE, Jensen E, Neff D, Polis AB, Tershakovec AM. Time-related trends in variability of cIMT changes in statin trials. Data Brief. 2016 Mar; 6:530-41. PMID: 26904712; PMCID: PMC4724693.
      Citations:    
    70. Reichenberg A, McMillan A, Trzaskowski M, Kapra O, Fruchter E, Ginat K, Davidson M, Weiser M, Larsson H, Plomin R, Lichtenstein P, Cederlöf M. Discontinuity in the genetic and environmental causes of the intellectual disability spectrum. Proc Natl Acad Sci U S A. 2016 01 26; 113(4):1098-103. PMID: 26711998; PMCID: PMC4743770.
      Citations: 41     Fields:    Translation:Humans
    71. Kumar R, Lu SK, Minchom A, Sharp A, Davidson M, Gunapala R, Yap TA, Bhosle J, Popat S, O'Brien ME. A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemother Pharmacol. 2016 Feb; 77(2):375-83. PMID: 26706729.
      Citations: 7     Fields:    Translation:Humans
    72. Narang A, Mor-Avi V, Bhave NM, Tarroni G, Corsi C, Davidson MH, Lang RM, Patel AR. Large high-density lipoprotein particle number is independently associated with microvascular function in patients with well-controlled low-density lipoprotein concentration: A vasodilator stress magnetic resonance perfusion study. J Clin Lipidol. 2016 Mar-Apr; 10(2):314-22. PMID: 27055962.
      Citations: 2     Fields:    Translation:Humans
    73. Weiser M, Goldberg S, Werbeloff N, Fenchel D, Reichenberg A, Shelef L, Large M, Davidson M, Fruchter E. Risk of completed suicide in 89,049 young males assessed by a mental health professional. Eur Neuropsychopharmacol. 2016 Feb; 26(2):341-349. PMID: 26712325.
      Citations: 8     Fields:    Translation:Humans
    74. Smith BA, Wright C, Davidson M. Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention. Curr Atheroscler Rep. 2015 Dec; 17(12):72. PMID: 26490081.
      Citations: 3     Fields:    Translation:Humans
    75. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY. Endocr Pract. 2015 Dec; 21(12):1403-14. PMID: 26642101.
      Citations: 10     Fields:    Translation:Humans
    76. Davidson MH, Tomassini JE, Jensen E, Neff D, Polis AB, Tershakovec AM. Changing characteristics of statin-related cIMT trials from 1988 to 2006. Atherosclerosis. 2016 Mar; 246:121-9. PMID: 26773471.
      Citations: 2     Fields:    Translation:Humans
    77. Weiser M, Kapra O, Werbeloff N, Goldberg S, Fenchel D, Reichenberg A, Yoffe R, Ginat K, Fruchter E, Davidson M. A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ. Schizophr Res. 2015 Dec; 169(1-3):159-164. PMID: 26490295.
      Citations: 5     Fields:    Translation:Humans
    78. Lomakin AJ, Han SJ, Bui DA, Davidson M, Danuser G, Lee KC, Mogilner A. Competition for actin between two distinct F-actin networks defines a bistable switch for cell polarization. Nat Cell Biol. 2015 Nov; 17(11):1435-45. PMID: 26414403; PMCID: PMC4628555.
      Citations: 99     Fields:    Translation:AnimalsCells
    79. Rossi JE, Noll A, Bergmark B, McCabe JM, Nemer D, Okada DR, Vasudevan A, Davidson M, Welt F, Eisenhauer A, Shah P, Giugliano R. Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience. Cardiol Ther. 2015 Dec; 4(2):197-201. PMID: 26399647; PMCID: PMC4675746.
      Citations: 6     
    80. Dunbar RL, Nicholls SJ, Maki KC, Roth EM, Orloff DG, Curcio D, Johnson J, Kling D, Davidson MH. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial. Lipids Health Dis. 2015 Sep 02; 14:98. PMID: 26328624; PMCID: PMC4557761.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    81. Brandt EJ, Regnier SM, Leung EK, Chou SH, Baron BW, Te HS, Davidson MH, Sargis RM. Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis. Clin Lipidol. 2015 Aug 01; 10(4):305-312. PMID: 26413163; PMCID: PMC4578808.
      Citations: 9     
    82. Thievessen I, Fakhri N, Steinwachs J, Kraus V, McIsaac RS, Gao L, Chen BC, Baird MA, Davidson MW, Betzig E, Oldenbourg R, Waterman CM, Fabry B. Vinculin is required for cell polarization, migration, and extracellular matrix remodeling in 3D collagen. FASEB J. 2015 Nov; 29(11):4555-67. PMID: 26195589; PMCID: PMC4608908.
      Citations: 48     Fields:    Translation:AnimalsCells
    83. Ritter AT, Asano Y, Stinchcombe JC, Dieckmann NM, Chen BC, Gawden-Bone C, van Engelenburg S, Legant W, Gao L, Davidson MW, Betzig E, Lippincott-Schwartz J, Griffiths GM. Actin depletion initiates events leading to granule secretion at the immunological synapse. Immunity. 2015 May 19; 42(5):864-76. PMID: 25992860; PMCID: PMC4448150.
      Citations: 154     Fields:    Translation:HumansCells
    84. Castle JW, Kent KP, Fan Y, Wallace KD, Davis CE, Roberts JC, Marino ME, Thomenius KE, Lim HW, Coles E, Davidson MH, Feinstein SB, DeMaria A. Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids. Atherosclerosis. 2015 Jul; 241(1):92-9. PMID: 25969892; PMCID: PMC4466163.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    85. Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin Drug Saf. 2015 Jun; 14(6):935-55. PMID: 25907232.
      Citations: 41     Fields:    Translation:Humans
    86. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr; 21(4):438-47. PMID: 25877012.
      Citations: 88     Fields:    Translation:Humans
    87. Guan Y, Rebane A, Lindquist JR, Davidson MW, Mazitschek R, Hughes TE, Drobizhev M, Shah JV, Meurer M, Raghavan S, Santos S, Kats I, Knop M. Live-cell multiphoton fluorescence correlation spectroscopy with an improved large Stokes shift fluorescent protein. Mol Biol Cell. 2015 Jun 01; 26(11):2054-66. PMID: 25877871; PMCID: PMC4472016.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    88. Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP, Pella D. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci. 2015 Mar 16; 11(1):1-23. PMID: 25861286; PMCID: PMC4379380.
      Citations: 116     
    89. Davidson MH. Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia. EBioMedicine. 2015 Apr; 2(4):284. PMID: 26137571; PMCID: PMC4486198.
      Citations: 1     Fields:    Translation:Humans
    90. Hookway C, Ding L, Davidson MW, Rappoport JZ, Danuser G, Gelfand VI. Microtubule-dependent transport and dynamics of vimentin intermediate filaments. Mol Biol Cell. 2015 May 01; 26(9):1675-86. PMID: 25717187; PMCID: PMC4436779.
      Citations: 41     Fields:    Translation:HumansCells
    91. Knowles EE, Weiser M, David AS, Glahn DC, Davidson M, Reichenberg A. The puzzle of processing speed, memory, and executive function impairments in schizophrenia: fitting the pieces together. Biol Psychiatry. 2015 Dec 01; 78(11):786-93. PMID: 25863361; PMCID: PMC4547909.
      Citations: 28     Fields:    Translation:Humans
    92. Rosenson RS, Davidson MH, Le NA, Burkle J, Pourfarzib R. Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy. Cardiovasc Drugs Ther. 2015 Feb; 29(1):41-50. PMID: 25702642.
      Citations: 9     Fields:    Translation:Humans
    93. Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014 Dec 16; 64(23):2525-40. PMID: 25500239.
      Citations: 88     Fields:    Translation:Humans
    94. Davidson MH, Bechtel DH. Assessment of the effect of esterified propoxylated glycerol (EPG) on the status of fat-soluble vitamins and select water-soluble nutrients following dietary administration to humans for 8 weeks. Regul Toxicol Pharmacol. 2014 Dec; 70 Suppl 2:S143-57. PMID: 25497998.
      Citations:    Fields:    Translation:Humans
    95. Singh A, Davidson M. Combination therapy with statins: who benefits? Endocrinol Metab Clin North Am. 2014 Dec; 43(4):993-1006. PMID: 25432393.
      Citations:    Fields:    Translation:Humans
    96. Ashikhmina E, Tomasello N, Connors JM, Jahanyar J, Davidson M, Mizuguchi KA. Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest. Ann Thorac Surg. 2014 Dec; 98(6):2215-6. PMID: 25468095.
      Citations: 1     Fields:    Translation:Humans
    97. Brinton EA, Kher U, Shah S, Cannon CP, Davidson M, Gotto AM, Ashraf TB, McCrary Sisk C, Dansky H, Mitchel Y, Barter P, DEFINE Investigators. Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial. J Clin Lipidol. 2015 Jan-Feb; 9(1):65-71. PMID: 25670362.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    98. Nikolic D, Mikhailidis DP, Davidson MH, Rizzo M, Banach M. ETC-1002: a future option for lipid disorders? Atherosclerosis. 2014 Dec; 237(2):705-10. PMID: 25463109.
      Citations: 11     Fields:    Translation:HumansAnimals
    99. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015 Feb 14; 36(7):449-56. PMID: 25273886.
      Citations: 84     Fields:    Translation:Humans
    100. Cai E, Ge P, Lee SH, Jeyifous O, Wang Y, Liu Y, Wilson KM, Lim SJ, Baird MA, Stone JE, Lee KY, Davidson MW, Chung HJ, Schulten K, Smith AM, Green WN, Selvin PR. Stable small quantum dots for synaptic receptor tracking on live neurons. Angew Chem Int Ed Engl. 2014 Nov 10; 53(46):12484-8. PMID: 25255882; PMCID: PMC4240739.
      Citations: 30     Fields:    Translation:AnimalsCells
    101. Davidson MH, Phillips AK, Kling D, Maki KC. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia. Expert Rev Cardiovasc Ther. 2014 Sep; 12(9):1045-54. PMID: 25089906.
      Citations: 2     Fields:    Translation:Humans
    102. Sreenivasappa H, Chaki SP, Lim SM, Trzeciakowski JP, Davidson MW, Rivera GM, Trache A. Selective regulation of cytoskeletal tension and cell-matrix adhesion by RhoA and Src. Integr Biol (Camb). 2014 Aug; 6(8):743-54. PMID: 24984203.
      Citations: 13     Fields:    Translation:AnimalsCells
    103. Sponseller CA, Morgan RE, Kryzhanovski VA, Campbell SE, Davidson MH. Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial. Clin Ther. 2014 Aug 01; 36(8):1211-22. PMID: 24998014.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    104. Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, Rubashkin MG, Magbanua MJ, Thorn KS, Davidson MW, Rugo HS, Park JW, Hammer DA, Bertozzi CR, Weaver VM, Giannone G. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 2014 Jul 17; 511(7509):319-25. PMID: 25030168; PMCID: PMC4487551.
      Citations: 293     Fields:    Translation:HumansAnimalsCells
    105. Sampson UK, Harrell FE, Fazio S, Nwosu S, Mercaldo N, Mensah GA, Davidson MH, Coll B, Feinstein SB. Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population. Echocardiography. 2015 Feb; 32(2):264-70. PMID: 24930883.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    106. Tam JM, Mansour MK, Khan NS, Seward M, Puranam S, Tanne A, Sokolovska A, Becker CE, Acharya M, Baird MA, Choi AM, Davidson MW, Segal BH, Lacy-Hulbert A, Stuart LM, Xavier RJ, Vyas JM. Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J Infect Dis. 2014 Dec 01; 210(11):1844-54. PMID: 24842831; PMCID: PMC4271056.
      Citations: 62     Fields:    Translation:AnimalsCells
    107. Davidson MH. Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus. Postgrad Med. 2014 May; 126(3):56-65. PMID: 24918792.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    108. Holden J, Davidson M, O'Halloran PD. Health coaching for low back pain: a systematic review of the literature. Int J Clin Pract. 2014 Aug; 68(8):950-62. PMID: 24754872.
      Citations: 7     Fields:    Translation:Humans
    109. Davidson MH, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Mazzone T, Carlson DM, Williams LA, Kelly MT, Camp HS, Lele A, Stolzenbach JC. Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST). Arterioscler Thromb Vasc Biol. 2014 Jun; 34(6):1298-306. PMID: 24743431.
      Citations: 28     Fields:    Translation:Humans
    110. Burnette DT, Shao L, Ott C, Pasapera AM, Fischer RS, Baird MA, Der Loughian C, Delanoe-Ayari H, Paszek MJ, Davidson MW, Betzig E, Lippincott-Schwartz J. A contractile and counterbalancing adhesion system controls the 3D shape of crawling cells. J Cell Biol. 2014 Apr 14; 205(1):83-96. PMID: 24711500; PMCID: PMC3987145.
      Citations: 99     Fields:    Translation:HumansAnimalsCells
    111. Harris WS, Davidson MH. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2014 Apr; 106(4):dju019. PMID: 24685928.
      Citations: 4     Fields:    Translation:Humans
    112. Herrmann H, Davidson MW, Gelfand VI, Robert A. Microtubule-dependent transport of vimentin filament precursors is regulated by actin and by the concerted action of Rho- and p21-activated kinases. FASEB J. 2014 Jul; 28(7):2879-90. PMID: 24652946; PMCID: PMC4062827.
      Citations: 36     Fields:    Translation:HumansCells
    113. Martin DD, Heit RJ, Yap MC, Davidson MW, Hayden MR, Berthiaume LG. Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin. Hum Mol Genet. 2014 Jun 15; 23(12):3166-79. PMID: 24459296; PMCID: PMC4030772.
      Citations: 28     Fields:    Translation:HumansCells
    114. Wilkinson MJ, Laffin LJ, Davidson MH. Overcoming toxicity and side-effects of lipid-lowering therapies. Best Pract Res Clin Endocrinol Metab. 2014 Jun; 28(3):439-52. PMID: 24840269.
      Citations: 17     Fields:    Translation:Humans
    115. Toth PP, Shah PK, Wilkinson MJ, Davidson MH, McCullough PA. Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice. Rev Cardiovasc Med. 2014; 15(1):1-10. PMID: 24762461.
      Citations: 2     Fields:    Translation:Humans
    116. Freed BH, Narang A, Bhave NM, Czobor P, Mor-Avi V, Zaran ER, Turner KM, Cavanaugh KP, Chandra S, Tanaka SM, Davidson MH, Lang RM, Patel AR. Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013 Dec 21; 15:108. PMID: 24359617; PMCID: PMC3878099.
      Citations: 16     Fields:    Translation:Humans
    117. Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013 Dec; 24(6):467-74. PMID: 24184945.
      Citations: 30     Fields:    Translation:HumansAnimals
    118. Wilkinson MJ, Davidson MH. Recent developments in the treatment of familial hypercholesterolemia: a review of several new drug classes. Curr Treat Options Cardiovasc Med. 2013 Dec; 15(6):696-705. PMID: 24222265.
      Citations:    
    119. IAS Panel for Global Recommendations for the Management of Dyslipidemia, Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Sadikot S, Santos RD, Susekov A, Sy R, Tokgozoglu L, Watts GF, Zhao D, International Society of Atherosclerosis, Kesäniemi YA. [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary]. Clin Investig Arterioscler. 2014 Jan-Feb; 26(1):33-7. PMID: 24169377.
      Citations: 1     Fields:    Translation:Humans
    120. Kastelein JJ, Maki KC, Susekov A, Ezhov M, Nordestgaard BG, Machielse BN, Kling D, Davidson MH. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. J Clin Lipidol. 2014 Jan-Feb; 8(1):94-106. PMID: 24528690.
      Citations: 61     Fields:    Translation:Humans
    121. Gotto AM, Cannon CP, Li XS, Vaidya S, Kher U, Brinton EA, Davidson M, Moon JE, Shah S, Dansky HM, Mitchel Y, Barter P, DEFINE Investigators. Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease. Am J Cardiol. 2014 Jan 01; 113(1):76-83. PMID: 24188894.
      Citations: 27     Fields:    Translation:Humans
    122. Offman E, Marenco T, Ferber S, Johnson J, Kling D, Curcio D, Davidson M. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study. Vasc Health Risk Manag. 2013; 9:563-73. PMID: 24124374; PMCID: PMC3794864.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    123. Kaneko T, Aranki S, Javed Q, McGurk S, Shekar P, Davidson M, Cohn L. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):117-26. PMID: 24079878.
      Citations: 22     Fields:    Translation:Humans
    124. Davidson MH. Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution. Nat Rev Cardiol. 2013 Nov; 10(11):618-9. PMID: 24019032.
      Citations: 3     Fields:    Translation:Humans
    125. Thomas GS, Cromwell WC, Ali S, Chin W, Flaim JD, Davidson M. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2013 Dec 10; 62(23):2178-84. PMID: 24013058.
      Citations: 87     Fields:    Translation:Humans
    126. Maki KC, Orloff DG, Nicholls SJ, Dunbar RL, Roth EM, Curcio D, Johnson J, Kling D, Davidson MH. A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial). Clin Ther. 2013 Sep; 35(9):1400-11.e1-3. PMID: 23998969.
      Citations: 38     Fields:    Translation:Humans
    127. Davidson MH, Voogt J, Luchoomun J, Decaris J, Killion S, Boban D, Glass A, Mohammad H, Lu Y, Villegas D, Neese R, Hellerstein M, Neff D, Musliner T, Tomassini JE, Turner S. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans. Atherosclerosis. 2013 Oct; 230(2):322-9. PMID: 24075764.
      Citations: 19     Fields:    Translation:HumansCells
    128. Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman MJ, Cuchel M, D'Agostino RB, Davidson MH, Davidson WS, Heinecke JW, Karas RH, Kontush A, Krauss RM, Miller M, Rader DJ. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013 Sep-Oct; 7(5):484-525. PMID: 24079290.
      Citations: 131     Fields:    Translation:HumansAnimals
    129. Davidson M. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients. Clin Ther. 2013 Aug; 35(8):1247-52. PMID: 23916045.
      Citations: 8     Fields:    Translation:Humans
    130. Stricker J, Beckham Y, Davidson MW, Gardel ML. Myosin II-mediated focal adhesion maturation is tension insensitive. PLoS One. 2013; 8(7):e70652. PMID: 23923013; PMCID: PMC3726642.
      Citations: 31     Fields:    Translation:HumansCells
    131. Thievessen I, Thompson PM, Berlemont S, Plevock KM, Plotnikov SV, Zemljic-Harpf A, Ross RS, Davidson MW, Danuser G, Campbell SL, Waterman CM. Vinculin-actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth. J Cell Biol. 2013 Jul 08; 202(1):163-77. PMID: 23836933; PMCID: PMC3704983.
      Citations: 137     Fields:    Translation:AnimalsCells
    132. Rubicz R, Zhu J, Laston S, Cole SA, Voruganti VS, Ebbesson SO, Howard BV, Maccluer JW, Davidson M, Umans JG, Comuzzie AG, Göring HH. Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study. Genet Epidemiol. 2013 Nov; 37(7):751-7. PMID: 23798484; PMCID: PMC3969261.
      Citations: 2     Fields:    Translation:HumansCells
    133. Ballantyne CM, Davidson MH, Macdougall DE, Bays HE, Dicarlo LA, Rosenberg NL, Margulies J, Newton RS. Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. J Am Coll Cardiol. 2013 Sep 24; 62(13):1154-62. PMID: 23770179.
      Citations: 50     Fields:    Translation:HumansCTClinical Trials
    134. Davidson MH, Rooney M, Pollock E, Drucker J, Choy Y. Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose. J Clin Lipidol. 2013 Sep-Oct; 7(5):423-32. PMID: 24079283.
      Citations: 3     Fields:    Translation:Humans
    135. Adams R, Brown GT, Davidson M, Fisher E, Mathisen J, Thomson G, Webster NR. Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review. Br J Anaesth. 2013 Nov; 111(5):703-10. PMID: 23748199.
      Citations: 17     Fields:    Translation:Humans
    136. Nitta M, Kishimoto T, Weiser M, Davidson M, Kane JM, Correll CU, Müller N. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull. 2013 Nov; 39(6):1230-41. PMID: 23720576; PMCID: PMC3796088.
      Citations: 80     Fields:    Translation:Humans
    137. Lu W, Fox P, Lakonishok M, Davidson MW, Gelfand VI. Initial neurite outgrowth in Drosophila neurons is driven by kinesin-powered microtubule sliding. Curr Biol. 2013 Jun 03; 23(11):1018-23. PMID: 23707427; PMCID: PMC3676710.
      Citations: 102     Fields:    Translation:AnimalsCells
    138. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013 May-Jun; 19(3):536-57. PMID: 23816937; PMCID: PMC4142590.
      Citations: 111     Fields:    Translation:Humans
    139. Davidson MH. Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction. J Clin Lipidol. 2013 May-Jun; 7(3 Suppl):S11-5. PMID: 23642323.
      Citations: 7     Fields:    Translation:Humans
    140. Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, Peuskens J, Hranov LG, Fleischhacker WW, EUFEST study group, Wobrock T, López-Ibor JJ, Gaebel W. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophr Res. 2013 Jun; 147(1):132-139. PMID: 23537477.
      Citations: 13     Fields:    Translation:Humans
    141. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH, American Association of Clinical Endocrinologists. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013 Mar-Apr; 19(2):327-36. PMID: 23598536.
      Citations: 139     Fields:    Translation:Animals
    142. Hovingh GK, Davidson MH, Kastelein JJ, O'Connor AM. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J. 2013 Apr; 34(13):962-71. PMID: 23416791.
      Citations: 60     Fields:    Translation:Humans
    143. Davidson MH, Tonstad S, Oparil S, Schwiers M, Day WW, Bowden CH. Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index =27 kg/m(2). Am J Cardiol. 2013 Apr 15; 111(8):1131-8. PMID: 23375187.
      Citations: 13     Fields:    Translation:Humans
    144. Aisen PS, Bierer LM, Davidson M, Ryan TM, Kaminsky R, Davis KL. Response to Combination Cholinergic/Noradrenergic Treatments in a Patient With Alzheimer's Disease. Am J Geriatr Psychiatry. 1993 Summer; 1(3):244-248. PMID: 28530925.
      Citations:    Fields:    
    145. Davidson MH. Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure? J Am Coll Cardiol. 2012 Dec 25; 60(25):2616-7. PMID: 23257304.
      Citations: 2     Fields:    Translation:Humans
    146. Davidson M, Liu SX, Barter P, Brinton EA, Cannon CP, Gotto AM, Leary ET, Shah S, Stepanavage M, Mitchel Y, Dansky HM. Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib. J Lipid Res. 2013 Feb; 54(2):467-72. PMID: 23172660; PMCID: PMC3588873.
      Citations: 19     Fields:    Translation:HumansCells
    147. Davidson MH. Cardio-diabetes: special considerations for the patient with diabetes and cardiovascular disease. Introduction. Am J Cardiol. 2012 Nov 06; 110(9 Suppl):1B-3B. PMID: 23062563.
      Citations:    Fields:    Translation:Humans
    148. Davidson MH. Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist. Am J Cardiol. 2012 Nov 06; 110(9 Suppl):43B-49B. PMID: 23062566.
      Citations: 15     Fields:    Translation:Humans
    149. Sullivan PF, Magnusson C, Reichenberg A, Boman M, Dalman C, Davidson M, Fruchter E, Hultman CM, Lundberg M, Weiser M, Svensson AC, Lichtenstein P, Långström N. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 2012 Nov; 69(11):1099-1103. PMID: 22752149; PMCID: PMC4187103.
      Citations: 101     Fields:    Translation:Humans
    150. Knowles EE, Weiser M, David AS, Dickinson D, Glahn D, Gold J, Davidson M, Reichenberg A. Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. Schizophr Res. 2012 Dec; 142(1-3):129-36. PMID: 23084540; PMCID: PMC4196269.
      Citations: 12     Fields:    Translation:Humans
    151. Geffen Y, Keefe R, Rabinowitz J, Anand R, Davidson M. Bl-1020, a new ?-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study. J Clin Psychiatry. 2012 Sep; 73(9):e1168-74. PMID: 23059159.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    152. Turner S, Voogt J, Davidson M, Glass A, Killion S, Decaris J, Mohammed H, Minehira K, Boban D, Murphy E, Luchoomun J, Awada M, Neese R, Hellerstein M. Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion. J Am Heart Assoc. 2012 Aug; 1(4):e001826. PMID: 23130164; PMCID: PMC3487360.
      Citations: 27     Fields:    
    153. Davidson M, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Setze C, Carlson DM, Stolzenbach J. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial. Cardiovasc Drugs Ther. 2012 Aug; 26(4):349-58. PMID: 22622962; PMCID: PMC3407355.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    154. Davidson MH. HDL and CETP Inhibition: Will This DEFINE the Future? Curr Treat Options Cardiovasc Med. 2012 Aug; 14(4):384-90. PMID: 22723175.
      Citations: 8     
    155. Cziraky MJ, Willey VJ, McKenney JM, Kamat SA, Fisher MD, Guyton JR, Jacobson TA, Davidson MH. Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting. J Clin Lipidol. 2013 Mar-Apr; 7(2):102-8. PMID: 23415428.
      Citations: 10     Fields:    Translation:Humans
    156. Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA, Abramovich Y, Amital D, Doron A, Konas S, Levkovitz Y, Liba D, Teitelbaum A, Mashiach M, Zimmerman Y. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. J Clin Psychiatry. 2012 Jun; 73(6):e728-34. PMID: 22795211.
      Citations: 39     Fields:    Translation:Humans
    157. Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, Davidson M, Rysz J, Banach M. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res. 2012 Oct; 51(4):314-24. PMID: 22609245.
      Citations: 71     Fields:    Translation:HumansAnimals
    158. Ferdinand KC, Davidson MH, Kelly MT, Setze CM. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response. Am J Cardiovasc Drugs. 2012 Apr 01; 12(2):117-25. PMID: 22263674.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    159. Roth EM, Rosenson RS, Jones PH, Davidson MH, Kelly MT, Setze CM, Lele A, Thakker K. Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies. J Clin Lipidol. 2012 Nov-Dec; 6(6):534-44. PMID: 23312049.
      Citations: 1     Fields:    Translation:Humans
    160. Chen F, Maccubbin D, Yan L, Sirah W, Chen E, Sisk CM, Davidson M, Blomqvist P, McKenney JM. Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia. Int J Cardiol. 2013 Jul 15; 167(1):225-31. PMID: 22305632.
      Citations: 5     Fields:    Translation:Humans
    161. Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study. J Clin Lipidol. 2012 Nov-Dec; 6(6):573-84. PMID: 23312053.
      Citations: 54     Fields:    Translation:HumansCells
    162. Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR. Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women. Vasc Health Risk Manag. 2012; 8:31-8. PMID: 22272073; PMCID: PMC3262484.
      Citations: 3     Fields:    Translation:Humans
    163. Banach M, Davidson M, Toth PP. Polish Lipid Association--a strong response to the problem of lipid disorders in Poland and Central and Eastern Europe. J Clin Lipidol. 2012 Mar-Apr; 6(2):105-7. PMID: 22385542.
      Citations: 2     Fields:    Translation:Humans
    164. Subach OM, Cranfill PJ, Davidson MW, Verkhusha VV. An enhanced monomeric blue fluorescent protein with the high chemical stability of the chromophore. PLoS One. 2011; 6(12):e28674. PMID: 22174863; PMCID: PMC3234270.
      Citations: 147     Fields:    Translation:HumansCells
    165. Toth PP, Ballantyne CM, Davidson MH, Tomassini JE, Ramey DR, Neff D, Tershakovec AM, Hu XH, Tunceli K. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction. J Clin Lipidol. 2012 Mar-Apr; 6(2):180-91. PMID: 22385552.
      Citations: 4     Fields:    Translation:Humans
    166. Davidson MH, Kling D, Maki KC. Novel developments in omega-3 fatty acid-based strategies. Curr Opin Lipidol. 2011 Dec; 22(6):437-44. PMID: 21986642.
      Citations: 9     Fields:    Translation:HumansAnimals
    167. Stalenhoef AF, Davidson MH, Robinson JG, Burgess T, Duttlinger-Maddux R, Kallend D, Goldberg AC, Bays H. Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk. Diabetes Obes Metab. 2012 Jan; 14(1):30-9. PMID: 21819519.
      Citations: 2     Fields:    Translation:Humans
    168. Sam S, Haffner S, Davidson MH, D'Agostino R, Perez A, Mazzone T. Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. J Clin Endocrinol Metab. 2012 Jan; 97(1):E110-4. PMID: 22072742; PMCID: PMC3412262.
      Citations: 6     Fields:    Translation:Humans
    169. Mangalmurti SS, Davidson MH. The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk. Curr Atheroscler Rep. 2011 Oct; 13(5):373-80. PMID: 21773803.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    170. Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol. 2011 Sep-Oct; 5(5):338-67. PMID: 21981835.
      Citations: 74     Fields:    Translation:Humans
    171. Davidson MH. Pharmacotherapy: Implications of high-dose statin link with incident diabetes. Nat Rev Cardiol. 2011 Aug 02; 8(10):543-4. PMID: 21808273.
      Citations: 4     Fields:    Translation:Humans
    172. Davidson MH, Plutzky J. The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction. Am J Cardiol. 2011 Aug 02; 108(3 Suppl):1B-2B. PMID: 21802576.
      Citations:    Fields:    Translation:Humans
    173. Davidson MH. Cardiovascular effects of glucagonlike peptide-1 agonists. Am J Cardiol. 2011 Aug 02; 108(3 Suppl):33B-41B. PMID: 21802579.
      Citations: 21     Fields:    Translation:HumansAnimals
    174. Ballantyne CM, Davidson MH, Setze CM, Kelly MT. Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu. J Clin Lipidol. 2011 Sep-Oct; 5(5):401-7. PMID: 21981842.
      Citations: 2     Fields:    Translation:Humans
    175. Bays HE, Davidson MH, Massaad R, Flaim D, Lowe RS, Tershakovec AM, Jones-Burton C. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study). Am J Cardiol. 2011 Aug 15; 108(4):523-30. PMID: 21596364.
      Citations: 19     Fields:    Translation:Humans
    176. Friedewald VE, Ballantyne CM, Davidson MH, Gotto AM, Ridker PM, Roberts WC. The editor's roundtable: JUPITER follow-up. Am J Cardiol. 2011 May 15; 107(10):1549-57. PMID: 21539951.
      Citations:    Fields:    Translation:Humans
    177. Berger JS, Ballantyne CM, Davidson MH, Johnson JL, Tarka EA, Lawrence D, Trivedi T, Zalewski A, Mohler ER. Peripheral artery disease, biomarkers, and darapladib. Am Heart J. 2011 May; 161(5):972-8. PMID: 21570531; PMCID: PMC3750980.
      Citations: 8     Fields:    Translation:Humans
    178. Maki KC, Davidson MH, Dicklin MR, Bell M, Witchger M, Feinstein SB. Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease. J Clin Lipidol. 2011 May-Jun; 5(3):141-151. PMID: 21600518.
      Citations: 11     Fields:    Translation:Humans
    179. Davidson MH. Focusing on high-density lipoprotein for coronary heart disease risk reduction. Cardiol Clin. 2011 Feb; 29(1):105-22. PMID: 21257103.
      Citations: 4     Fields:    Translation:Humans
    180. Davidson MH. Therapies targeting exogenous cholesterol uptake: new insights and controversies. Curr Atheroscler Rep. 2011 Feb; 13(1):95-100. PMID: 21188557.
      Citations: 1     Fields:    Translation:HumansAnimals
    181. Davidson MH. A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia. J Clin Lipidol. 2011 Mar-Apr; 5(2):76-81. PMID: 21392720.
      Citations: 14     Fields:    Translation:Humans
    182. Brown WV, Bays H, Davidson M, Goldberg A. Drugs in development for management of lipoprotein disorders. J Clin Lipidol. 2011 Mar-Apr; 5(2):66-75. PMID: 21392719.
      Citations: 1     Fields:    Translation:HumansAnimals
    183. Davidson MH. Apolipoprotein A-I therapy promise, challenges, and disappointment. J Am Coll Cardiol. 2011 Mar 01; 57(9):1120-1. PMID: 21255956.
      Citations: 5     Fields:    Translation:Humans
    184. Gilbert J, Lekstrom-Himes J, Donaldson D, Lee Y, Hu M, Xu J, Wyant T, Davidson M, MLN1202 Study Group. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region. Am J Cardiol. 2011 Mar 15; 107(6):906-11. PMID: 21247529.
      Citations: 73     Fields:    Translation:HumansCellsCTClinical Trials
    185. Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, Stepanavage M, Liu SX, Gibbons P, Ashraf TB, Zafarino J, Mitchel Y, Barter P, Determining the Efficacy and Tolerability Investigators. Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med. 2010 Dec 16; 363(25):2406-15. PMID: 21082868.
      Citations: 220     Fields:    Translation:Humans
    186. Davidson MH. Should niacin be the preferred drug to add to a statin? Curr Cardiol Rep. 2010 Nov; 12(6):447-9. PMID: 20820952.
      Citations:    Fields:    
    187. Weiser M, Werbeloff N, Levine A, Livni G, Schreiber S, Halperin D, Yoffe R, Davidson M. CNS infection in childhood does not confer risk for later schizophrenia: a case-control study. Schizophr Res. 2010 Dec; 124(1-3):231-5. PMID: 20846826.
      Citations: 3     Fields:    Translation:Humans
    188. Toth PP, Davidson MH. High-density lipoproteins: marker of cardiovascular risk and therapeutic target. J Clin Lipidol. 2010 Sep-Oct; 4(5):359-64. PMID: 21122679.
      Citations: 7     Fields:    Translation:Humans
    189. Davidson MH. Update on CETP inhibition. J Clin Lipidol. 2010 Sep-Oct; 4(5):394-8. PMID: 21122682.
      Citations: 12     Fields:    Translation:HumansCells
    190. Davidson MH, Beam CA, Haffner S, Perez A, D'Agostino R, Mazzone T. Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study. Arterioscler Thromb Vasc Biol. 2010 Sep; 30(9):1873-6. PMID: 20576945; PMCID: PMC2945383.
      Citations: 4     Fields:    Translation:Humans
    191. Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PM, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA, Garris M, Otieno FG, Davidson M, Weiser M, Reichenberg A, Davis KL, Friedman JI, Cappola TP, Margulies KB, Rader DJ, Grant SF, Buxbaum JD, Gur RE, Hakonarson H. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A. 2010 Jun 08; 107(23):10584-9. PMID: 20489179; PMCID: PMC2890845.
      Citations: 108     Fields:    Translation:HumansCells
    192. Rosenson RS, Davidson MH, Pourfarzib R. Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk. Atherosclerosis. 2010 Nov; 213(1):1-7. PMID: 20451205.
      Citations: 15     Fields:    Translation:Humans
    193. Maki KC, Dicklin MR, Davidson MH, Doyle RT, Ballantyne CM, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy. Am J Cardiol. 2010 May 15; 105(10):1409-12. PMID: 20451686.
      Citations: 4     Fields:    Translation:Humans
    194. Fang Z, Takizawa N, Wilson KA, Smith TC, Delprato A, Davidson MW, Lambright DG, Luna EJ. The membrane-associated protein, supervillin, accelerates F-actin-dependent rapid integrin recycling and cell motility. Traffic. 2010 Jun; 11(6):782-99. PMID: 20331534; PMCID: PMC2888608.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    195. Davidson MH. Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence. J Clin Lipidol. 2010 Jan-Feb; 4(1):72-3; discussion 74. PMID: 21122630.
      Citations:    Fields:    Translation:Humans
    196. Braun LT, Davidson MH. Lp-PLA2: A new target for statin therapy. Curr Atheroscler Rep. 2010 Jan; 12(1):29-33. PMID: 20425268.
      Citations: 8     Fields:    Translation:Humans
    197. Argenziano M, Skipper E, Heimansohn D, Letsou GV, Woo YJ, Kron I, Alexander J, Cleveland J, Kong B, Davidson M, Vassiliades T, Krieger K, Sako E, Tibi P, Galloway A, Foster E, Feldman T, Glower D, EVEREST Investigators. Surgical revision after percutaneous mitral repair with the MitraClip device. Ann Thorac Surg. 2010 Jan; 89(1):72-80; discussion p 80. PMID: 20103209.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    198. Jones PH, Cusi K, Davidson MH, Kelly MT, Setze CM, Thakker K, Sleep DJ, Stolzenbach JC. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials. Am J Cardiovasc Drugs. 2010; 10(2):73-84. PMID: 20136164.
      Citations: 9     Fields:    Translation:Humans
    199. Ohsfeldt RL, Gandhi SK, Fox KM, Bullano MF, Davidson M. Medical and cost burden of atherosclerosis among patients treated in routine clinical practice. J Med Econ. 2010; 13(3):500-7. PMID: 20673198.
      Citations: 12     Fields:    Translation:Humans
    200. Davidson MH, Donovan JM, Misir S, Jones MR. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia. Am J Cardiovasc Drugs. 2010; 10(5):305-14. PMID: 20860413.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    201. Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS, Tershakovec AM. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category. Metab Syndr Relat Disord. 2009 Dec; 7(6):601-10. PMID: 19929597.
      Citations: 4     Fields:    Translation:Humans
    202. Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. Clin Ther. 2009 Dec; 31(12):2824-38. PMID: 20110022.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    203. Davidson MH, Rosenson RS. Novel targets that affect high-density lipoprotein metabolism: the next frontier. Am J Cardiol. 2009 Nov 16; 104(10 Suppl):52E-7E. PMID: 19895945.
      Citations: 5     Fields:    Translation:Humans
    204. Davidson MH. Focus on HDL as a therapeutic target for CAD risk reduction. Am J Cardiol. 2009 Nov 16; 104(10 Suppl):1E-2E. PMID: 19895937.
      Citations:    Fields:    Translation:Humans
    205. Deedwania P, Singh V, Davidson MH. Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials. Am J Cardiol. 2009 Nov 16; 104(10 Suppl):3E-9E. PMID: 19895938.
      Citations: 2     Fields:    Translation:Humans
    206. Davidson MH. AURORA and JUPITER trials: recognizing the limitations and expanding the benefits of statin treatment. Curr Cardiol Rep. 2009 Nov; 11(6):401-3. PMID: 19863863.
      Citations: 1     Fields:    
    207. Davidson MH. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time. J Fam Pract. 2009 Nov; 58(11 Suppl Urgent):S26-31. PMID: 19891945.
      Citations:    Fields:    Translation:Humans
    208. Boter H, Derks EM, Fleischhacker WW, Davidson M, EUFEST Study Group, Kahn RS. Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST). J Clin Psychiatry. 2010 Jan; 71(1):58-65. PMID: 19852905.
      Citations: 5     Fields:    Translation:Humans
    209. Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, EUFEST study group, Kahn RS. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophr Res. 2009 Dec; 115(2-3):97-103. PMID: 19819114.
      Citations: 41     Fields:    Translation:HumansPHPublic Health
    210. Davidson MH. A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al. Cardiovasc Drugs Ther. 2009 Oct; 23(5):341-2. PMID: 19844785.
      Citations:    Fields:    Translation:HumansAnimals
    211. Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, Bell M, McGuire DK, Provost JC, Liker H, Aviram M. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol. 2009 Oct 01; 104(7):936-42. PMID: 19766760.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    212. Cannon CP, Dansky HM, Davidson M, Gotto AM, Brinton EA, Gould AL, Stepanavage M, Liu SX, Shah S, Rubino J, Gibbons P, Hermanowski-Vosatka A, Binkowitz B, Mitchel Y, Barter P, DEFINE investigators. Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. Am Heart J. 2009 Oct; 158(4):513-519.e3. PMID: 19781408.
      Citations: 24     Fields:    Translation:Humans
    213. Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA, American College of Cardiology Foundation, American Heart Association, American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a, American Academy of Neurology, American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Preventive Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, National Lipid Association, Preventive Cardiovascular Nurses Association. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2009 Sep 29; 54(14):1336-63. PMID: 19778678; PMCID: PMC2782747.
      Citations: 11     Fields:    Translation:Humans
    214. Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA, American Academy of Neurology, American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Preventive Medicine, American College of Sports Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, Centers for Disease Control and Prevention, National Heart, Lung, and Blood Institute, National Lipid Association, Preventive Cardiovascular Nurses Association. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. Circulation. 2009 Sep 29; 120(13):e100-26. PMID: 19770387.
      Citations: 10     Fields:    Translation:Humans
    215. Davidson MH. Apolipoprotein measurements: is more widespread use clinically indicated? Clin Cardiol. 2009 Sep; 32(9):482-6. PMID: 19743499; PMCID: PMC6653425.
      Citations: 34     Fields:    Translation:Humans
    216. Davidson MH, Maki KC, Bays H, Carter R, Ballantyne CM. Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemia. J Clin Lipidol. 2009 Oct; 3(5):332-40. PMID: 21291831.
      Citations: 20     Fields:    
    217. Davidson MH, Fox KM, Gandhi SK, Ohsfeldt RL, McKenney JM. Medical management of patients before the incidence of a cardiovascular event. J Clin Lipidol. 2009 Oct; 3(5):315-21. PMID: 21291830.
      Citations:    Fields:    
    218. Sam S, Haffner S, Davidson MH, D'Agostino RB, Feinstein S, Kondos G, Perez A, Mazzone T. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009 Oct; 32(10):1916-20. PMID: 19592623; PMCID: PMC2752928.
      Citations: 72     Fields:    Translation:Humans
    219. Maccubbin D, Koren MJ, Davidson M, Gavish D, Pasternak RC, Macdonell G, Mallick M, Sisk CM, Paolini JF, Mitchel Y. Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease. Am J Cardiol. 2009 Jul 01; 104(1):74-81. PMID: 19576324.
      Citations: 20     Fields:    Translation:Humans
    220. Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio M, Silverstein RL. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring). 2009 Dec; 17(12):2142-8. PMID: 19521352; PMCID: PMC2836489.
      Citations: 29     Fields:    Translation:HumansCells
    221. Davidson MH. Pharmacological approaches to modifying HDL: more basic science to understand HDL metabolism is necessary. Editorial to: "NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells" by Xin Ma et al. Cardiovasc Drugs Ther. 2009 Jun; 23(3):187-8. PMID: 19434486.
      Citations:    Fields:    Translation:HumansCells
    222. Ridker PM, Friedewald VE, Davidson MH, Willerson JT, Roberts WC. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Am J Cardiol. 2009 May 15; 103(10):1417-25. PMID: 19427439.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    223. Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, Hranov LG, Gaebel W, Peuskens J, Lindefors N, López-Ibor JJ, Riecher-Rössler A, Kahn RS. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry. 2009 Jun; 166(6):675-82. PMID: 19369319.
      Citations: 87     Fields:    Translation:Humans
    224. Polonsky T, Mazzone T, Davidson M. The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus. Trends Cardiovasc Med. 2009 Apr; 19(3):94-9. PMID: 19679266.
      Citations: 3     Fields:    Translation:Humans
    225. Dembowski E, Davidson MH. Statin and ezetimibe combination therapy in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):183-8. PMID: 19262375.
      Citations: 5     Fields:    Translation:HumansAnimals
    226. Meuwese MC, de Groot E, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA, CAPTIVATE Investigators, Duivenvoorden R. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. JAMA. 2009 Mar 18; 301(11):1131-9. PMID: 19293413.
      Citations: 45     Fields:    Translation:HumansCTClinical Trials
    227. Sam S, Haffner S, Davidson MH, D'Agostino RB, Feinstein S, Kondos G, Perez A, Mazzone T. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009 May; 32(5):932-7. PMID: 19228869; PMCID: PMC2671130.
      Citations: 45     Fields:    Translation:Humans
    228. Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Am J Kidney Dis. 2009 May; 53(5):741-50. PMID: 19216014.
      Citations: 35     Fields:    Translation:Humans
    229. Jones PH, Davidson MH, Goldberg AC, Pepine CJ, Kelly MT, Buttler SM, Setze CM, Lele A, Sleep DJ, Stolzenbach JC. Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies. J Clin Lipidol. 2009 Apr; 3(2):125-37. PMID: 21291802.
      Citations: 9     Fields:    
    230. Davidson MH, Gandhi SK, Ohsfeldt RL, Fox KM. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice. Am J Med. 2009 Jan; 122(1 Suppl):S51-9. PMID: 19110088.
      Citations: 2     Fields:    Translation:Humans
    231. Borden WB, Davidson MH. Updating the assessment of cardiac risk: beyond Framingham. Rev Cardiovasc Med. 2009; 10(2):63-71. PMID: 19593318.
      Citations: 5     Fields:    Translation:Humans
    232. Kawata AK, Revicki DA, Thakkar R, Jiang P, Krause S, Davidson MH, Punzi HA, Padley RJ. Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy. Clin Drug Investig. 2009; 29(4):215-29. PMID: 19301936.
      Citations: 8     Fields:    Translation:Humans
    233. Davidson MH. Novel nonstatin strategies to lower low-density lipoprotein cholesterol. Curr Atheroscler Rep. 2009 Jan; 11(1):67-70. PMID: 19080731.
      Citations: 14     Fields:    Translation:HumansAnimals
    234. Dembowski E, Davidson MH. A review of lipid management in primary and secondary prevention. J Cardiopulm Rehabil Prev. 2009 Jan-Feb; 29(1):2-12. PMID: 19158581.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    235. Davidson M. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome. Am J Cardiol. 2008 Dec 22; 102(12A):19L-27L. PMID: 19084086.
      Citations: 6     Fields:    Translation:Humans
    236. Caspi A, Vishne T, Reichenberg A, Weiser M, Dishon A, Lubin G, Shmushkevitz M, Mandel Y, Noy S, Davidson M. Refractive errors and schizophrenia. Schizophr Res. 2009 Feb; 107(2-3):238-41. PMID: 19019632.
      Citations: 8     Fields:    Translation:Humans
    237. Davidson MH. METEOR and ENHANCE: a tale of two CIMT trials: part 2. Curr Cardiol Rep. 2008 Nov; 10(6):479-80. PMID: 18950558.
      Citations: 1     Fields:    
    238. Davidson MH. METEOR and ENHANCE: a tale of two CIMT trials: part 1. Curr Cardiol Rep. 2008 Nov; 10(6):479. PMID: 18950557.
      Citations:    Fields:    
    239. Davidson MH, Dembowski E. Atherosclerosis surrogate imaging trials come of age: for better or for worse? Curr Cardiol Rep. 2008 Nov; 10(6):521-5. PMID: 18950564.
      Citations: 2     Fields:    Translation:Humans
    240. Paolini JF, Bays HE, Ballantyne CM, Davidson M, Pasternak R, Maccubbin D, Norquist JM, Lai E, Waters MG, Kuznetsova O, Sisk CM, Mitchel YB. Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors. Cardiol Clin. 2008 Nov; 26(4):547-60. PMID: 19031552.
      Citations: 6     Fields:    Translation:HumansAnimals
    241. Davidson MB, Wong A, Hamrahian AH, Stevens M, Siraj ES. Effect of spironolactone therapy on albuminuria in patients with type 2 diabetes treated with angiotensin-converting enzyme inhibitors. Endocr Pract. 2008 Nov; 14(8):985-92. PMID: 19095597.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    242. Ming EE, Davidson MH, Gandhi SK, Marotti M, Miles CG, Ke X, McKenney JM. Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases. J Clin Lipidol. 2008 Dec; 2(6):453-63. PMID: 21291779.
      Citations: 18     Fields:    
    243. Davidson MH, Abate N, Ballantyne CM, Catapano AL, Xu X, Lin J, Rosenberg E, Tershakovec AM. Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. J Clin Lipidol. 2008 Dec; 2(6):436-46. PMID: 21291777.
      Citations: 7     Fields:    
    244. Jones PH, Davidson MH, Kashyap ML, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC. Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study. Atherosclerosis. 2009 May; 204(1):208-15. PMID: 18996523.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    245. Friedewald VE, Ballantyne CM, Davidson MH, Guyton JR, Roberts WC. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk. Am J Cardiol. 2008 Sep 01; 102(5):559-67. PMID: 18721512.
      Citations: 4     Fields:    Translation:Humans
    246. Davidson MH. Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment. Arterioscler Thromb Vasc Biol. 2008 Sep; 28(9):1582-3. PMID: 18716322.
      Citations: 11     Fields:    Translation:Humans
    247. Kemp AS, Schooler NR, Kalali AH, Alphs L, Anand R, Awad G, Davidson M, Ereshefsky L, Gharabawi G, Leon AC, Lepine JP, Potkin SG, Vermeulen A, Dubé S. What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull. 2010 May; 36(3):504-9. PMID: 18723840; PMCID: PMC2879679.
      Citations: 45     Fields:    Translation:Humans
    248. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008 Oct; 5(10):621-35. PMID: 18711404; PMCID: PMC2639398.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    249. Robinson JG, Davidson M. Is it over for ezetimibe? Expert Rev Cardiovasc Ther. 2008 Jul; 6(6):781-3. PMID: 18570614.
      Citations: 1     Fields:    Translation:Humans
    250. Davidson MH. Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications. Cleve Clin J Med. 2008 Jul; 75(7):479-82, 486-8, 490-1. PMID: 18646584.
      Citations: 3     Fields:    Translation:Humans
    251. Dembowski E, Davidson MH. Should every patient with diabetes receive a statin? Pol Arch Med Wewn. 2008 Jul-Aug; 118(7-8):398-401. PMID: 18714733.
      Citations:    Fields:    Translation:HumansPHPublic Health
    252. Charland SL, Cziraky MJ, Quimbo R, Karas RH, Insull W, Davidson M, Stanek EJ. Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular events. J Clin Lipidol. 2008 Oct; 2(5):343-53. PMID: 21291759.
      Citations:    Fields:    
    253. Corson MA, Jones PH, Davidson MH. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Am J Cardiol. 2008 Jun 16; 101(12A):41F-50F. PMID: 18549871.
      Citations: 35     Fields:    Translation:Humans
    254. Davidson MH, Corson MA, Alberts MJ, Anderson JL, Gorelick PB, Jones PH, Lerman A, McConnell JP, Weintraub HS. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol. 2008 Jun 16; 101(12A):51F-57F. PMID: 18549872.
      Citations: 46     Fields:    Translation:Humans
    255. Davidson MH. Introduction. U.S. incidence of coronary artery disease. Am J Cardiol. 2008 Jun 16; 101(12A):1F-2F. PMID: 18549866.
      Citations: 1     Fields:    Translation:Humans
    256. Beeri MS, Davidson M, Silverman JM, Schmeidler J, Springer RR, Noy S, Goldbourt U. Religious education and midlife observance are associated with dementia three decades later in Israeli men. J Clin Epidemiol. 2008 Nov; 61(11):1161-8. PMID: 18538995; PMCID: PMC2911134.
      Citations: 10     Fields:    Translation:Humans
    257. Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study). Am J Cardiol. 2008 May 15; 101(10):1428-36. PMID: 18471454.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    258. Sam S, Haffner S, Davidson MH, D'Agostino RB, Feinstein S, Kondos G, Perez A, Mazzone T. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes. 2008 Aug; 57(8):2022-7. PMID: 18469202; PMCID: PMC2494673.
      Citations: 46     Fields:    Translation:Humans
    259. Toth PP, Davidson MH. High-dose statin therapy: benefits and safety in aggressive lipid lowering. J Fam Pract. 2008 May; 57(5 Suppl High-Dose):S29-36. PMID: 18662521.
      Citations: 1     Fields:    Translation:Humans
    260. Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother. 2008 May; 9(7):1237-48. PMID: 18422480.
      Citations: 32     Fields:    Translation:Humans
    261. Mohler ER, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A, Darapladib Investigators. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 2008 Apr 29; 51(17):1632-41. PMID: 18436114.
      Citations: 73     Fields:    Translation:HumansCTClinical Trials
    262. Davidson MH, Ballantyne CM. Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction. Am J Cardiol. 2008 Apr 17; 101(8A):1B-2B. PMID: 18375235.
      Citations: 1     Fields:    Translation:Humans
    263. Davidson MH. Niacin use and cutaneous flushing: mechanisms and strategies for prevention. Am J Cardiol. 2008 Apr 17; 101(8A):14B-19B. PMID: 18375236.
      Citations: 13     Fields:    Translation:Humans
    264. Polonsky TS, Davidson MH. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy. Am J Cardiol. 2008 Apr 17; 101(8A):27B-35B. PMID: 18375238.
      Citations: 4     Fields:    Translation:Humans
    265. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008 Apr 15; 51(15):1512-24. PMID: 18402913.
      Citations: 164     Fields:    Translation:Humans
    266. Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R, Kondos GT, Perez A, Chen Z, Mazzone T. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation. 2008 Apr 22; 117(16):2123-30. PMID: 18413496.
      Citations: 47     Fields:    Translation:Humans
    267. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL, American Diabetes Association, American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008 Apr; 31(4):811-22. PMID: 18375431.
      Citations: 153     Fields:    Translation:Humans
    268. Davidson MH. Interrupting bile-acid handling and lipid and glucose control: Effects of colesevelam on glucose levels. J Clin Lipidol. 2008 Apr; 2(2):S29-33. PMID: 21291718.
      Citations: 2     Fields:    
    269. Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther. 2008 Mar; 6(3):391-409. PMID: 18327998.
      Citations: 64     Fields:    Translation:Humans
    270. Abate N, Catapano AL, Ballantyne CM, Davidson MH, Polis A, Smugar SS, Tershakovec AM. Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses. J Clin Lipidol. 2008 Apr; 2(2):91-105. PMID: 21291725.
      Citations: 3     Fields:    
    271. Ballantyne CM, Davidson MH, McKenney JM, Keller LH, Bajorunas DR, Karas RH. Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study. J Clin Lipidol. 2008 Apr; 2(2):79-90. PMID: 21291724.
      Citations: 13     Fields:    
    272. Stein JH, Tzou WS, DeCara JM, Hirsch AT, Mohler ER, Ouyang P, Pearce GL, Davidson MH. Usefulness of increased skin cholesterol to identify individuals at increased cardiovascular risk (from the Predictor of Advanced Subclinical Atherosclerosis study). Am J Cardiol. 2008 Apr 01; 101(7):986-91. PMID: 18359319.
      Citations: 8     Fields:    Translation:Humans
    273. Karas RH, Kashyap ML, Knopp RH, Keller LH, Bajorunas DR, Davidson MH. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study. Am J Cardiovasc Drugs. 2008; 8(2):69-81. PMID: 18422390.
      Citations: 24     Fields:    Translation:Humans
    274. Davidson MH, Jones PH. Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet. Clin Drug Investig. 2008; 28(10):615-23. PMID: 18783300.
      Citations: 3     Fields:    Translation:Humans
    275. Jones PH, Bays HE, Davidson MH, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC. Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme. Clin Drug Investig. 2008; 28(10):625-34. PMID: 18783301.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    276. Brotman DJ, Davidson MB, Boumitri M, Vidt DG. Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 2008 Jan; 21(1):92-7. PMID: 18091750.
      Citations: 47     Fields:    Translation:Humans
    277. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008 Mar; 197(1):12-24. PMID: 18160071.
      Citations: 143     Fields:    Translation:HumansAnimals
    278. Paolini JF, Mitchel YB, Reyes R, Kher U, Lai E, Watson DJ, Norquist JM, Meehan AG, Bays HE, Davidson M, Ballantyne CM. Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. Am J Cardiol. 2008 Mar 01; 101(5):625-30. PMID: 18308010.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    279. Davidson MH, Toth PP. High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol. 2007 Dec 03; 100(11 A):n32-40. PMID: 18047851.
      Citations: 18     Fields:    Translation:Humans
    280. Davidson MH. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors. Am J Manag Care. 2007 Dec; 13 Suppl 10:S260-9. PMID: 18095776.
      Citations: 3     Fields:    Translation:Humans
    281. Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Am J Manag Care. 2007 Dec; 13 Suppl 10:S270-5. PMID: 18095777.
      Citations: 7     Fields:    Translation:Humans
    282. Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Clin Ther. 2007 Nov; 29(11):2385-94. PMID: 18158079.
      Citations: 1     Fields:    Translation:Humans
    283. Weiser M, Reichenberg A, Rabinowitz J, Nahon D, Kravitz E, Lubin G, Knobler HY, Davidson M, Noy S. Impaired reading comprehension and mathematical abilities in male adolescents with average or above general intellectual abilities are associated with comorbid and future psychopathology. J Nerv Ment Dis. 2007 Nov; 195(11):883-90. PMID: 18000449.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    284. Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH. Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data. Int J Clin Pract. 2007 Oct; 61(10):1634-42. PMID: 17877650; PMCID: PMC2040184.
      Citations: 1     Fields:    Translation:Humans
    285. Davidson MH. The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review. Expert Opin Pharmacother. 2007 Oct; 8(15):2569-78. PMID: 17931091.
      Citations: 6     Fields:    Translation:HumansAnimals
    286. Maki KC, Davidson MH, Witchger MS, Dicklin MR, Subbaiah PV. Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men. Int J Vitam Nutr Res. 2007 Sep; 77(5):347-56. PMID: 18453320.
      Citations: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
    287. Davidson MH, Smith J, Scott R, Small R, Choi J, Ishida BY, Kane JP, ALPS Investigators. Assessment of lipoprotein profiles study (ALPS) and antioxidant activity in healthy subjects treated with AGI-1067. J Clin Lipidol. 2007 Aug; 1(4):271-9. PMID: 21291691.
      Citations: 1     Fields:    
    288. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2007 Jul; 29(7):1354-67. PMID: 17825687.
      Citations: 114     Fields:    Translation:Humans
    289. Kamat SA, Gandhi SK, Davidson M. Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals. Curr Med Res Opin. 2007 May; 23(5):1121-30. PMID: 17519079.
      Citations: 5     Fields:    Translation:Humans
    290. Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J, Henik R, Labato M, Littman M, Polzin D, Ross L, Snyder P, Stepien R, American College of Veterinary Internal Medicine. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2007 May-Jun; 21(3):542-58. PMID: 17552466.
      Citations: 133     Fields:    Translation:Animals
    291. Davidson M, Emsley R, Kramer M, Ford L, Pan G, Lim P, Eerdekens M. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Schizophr Res. 2007 Jul; 93(1-3):117-30. PMID: 17466492.
      Citations: 75     Fields:    Translation:Humans
    292. Davidson MH, Robinson JG. Safety of aggressive lipid management. J Am Coll Cardiol. 2007 May 01; 49(17):1753-62. PMID: 17466224.
      Citations: 39     Fields:    Translation:Humans
    293. Goldbourt U, Schnaider-Beeri M, Davidson M. Socioeconomic status in relationship to death of vascular disease and late-life dementia. J Neurol Sci. 2007 Jun 15; 257(1-2):177-81. PMID: 17395207.
      Citations: 12     Fields:    Translation:Humans
    294. Bartels DW, Davidson MH, Gong WC. Type 2 diabetes and cardiovascular disease: reducing the risk. J Manag Care Pharm. 2007 Mar; 13(2 Suppl A):S2-15; quiz S16-7. PMID: 17330977; PMCID: PMC10437557.
      Citations: 8     Fields:    Translation:Humans
    295. Maki KC, Rains TM, Kaden VN, Raneri KR, Davidson MH. Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults. Am J Clin Nutr. 2007 Mar; 85(3):724-34. PMID: 17344493.
      Citations: 35     Fields:    Translation:HumansPHPublic Health
    296. Mazzone T, Meyer PM, Kondos GT, Davidson MH, Feinstein SB, D'Agostino RB, Perez A, Haffner SM. Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes. Diabetes. 2007 Mar; 56(3):849-55. PMID: 17327456.
      Citations: 9     Fields:    Translation:Humans
    297. Davidson MH. Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease. Am Heart Hosp J. 2007; 5(4):210-6. PMID: 17982304.
      Citations: 2     Fields:    Translation:Humans
    298. Davidson MH. Squalene synthase inhibition: a novel target for the management of dyslipidemia. Curr Atheroscler Rep. 2007 Jan; 9(1):78-80. PMID: 17169251.
      Citations: 10     Fields:    Translation:Humans
    299. Davidson MH. Rosuvastatin in elderly patients. Drugs Aging. 2007; 24(11):933-44. PMID: 17953460.
      Citations: 4     Fields:    Translation:Humans
    300. Davidson MH. The PROACTIVE Study and reduction of cardiovascular events in patients with diabetes. Curr Atheroscler Rep. 2007 Jan; 9(1):45. PMID: 17169244.
      Citations:    Fields:    
    301. Davidson MH. The ASPEN Study and reduction of cardiovascular events in patients with diabetes. Curr Atheroscler Rep. 2007 Jan; 9(1):46-7. PMID: 17169245.
      Citations:    Fields:    
    302. Davidson MH. The FIELD Study and reduction of cardiovascular events in patients with diabetes. Curr Atheroscler Rep. 2007 Jan; 9(1):46. PMID: 17169246.
      Citations:    Fields:    
    303. Davidson MH, Basile J, Garber AJ, Phillips RA. Reducing the risk of stroke through appropriate targets and treatments. Prev Cardiol. 2007; 10(4):215-21. PMID: 17917519.
      Citations:    Fields:    Translation:Humans
    304. Davidson MH. Global risk management in patients with type 2 diabetes mellitus. Am J Cardiol. 2007 Feb 19; 99(4A):41B-50B. PMID: 17307057.
      Citations:    Fields:    Translation:Humans
    305. Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate therapy. Am J Cardiol. 2007 Mar 19; 99(6A):3C-18C. PMID: 17368275.
      Citations: 111     Fields:    Translation:Humans
    306. Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino RB, Perez A, Provost JC, Haffner SM. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA. 2006 Dec 06; 296(21):2572-81. PMID: 17101640.
      Citations: 202     Fields:    Translation:Humans
    307. Davidson MH, McKenney JM, Shear CL, Revkin JH. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels. J Am Coll Cardiol. 2006 Nov 07; 48(9):1774-81. PMID: 17084249.
      Citations: 30     Fields:    Translation:Humans
    308. McKenney JM, Davidson MH, Shear CL, Revkin JH. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin. J Am Coll Cardiol. 2006 Nov 07; 48(9):1782-90. PMID: 17084250.
      Citations: 31     Fields:    Translation:Humans
    309. Ansell BJ, Fonarow GC, Maki KC, Dicklin MR, Bell M, Davidson MH, NEPTUNE II Steering Committee. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Am Heart J. 2006 Nov; 152(5):976-81. PMID: 17070174.
      Citations: 12     Fields:    Translation:Humans
    310. Davidson MH. Differences between clinical trial efficacy and real-world effectiveness. Am J Manag Care. 2006 Nov; 12(15 Suppl):S405-11. PMID: 17112328.
      Citations: 18     Fields:    Translation:Humans
    311. Davidson MH. Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia? Nat Clin Pract Cardiovasc Med. 2006 Nov; 3(11):594-5. PMID: 17063163.
      Citations:    Fields:    
    312. Davidson M, Zhu J, Lu W, Tracy RP, Robbins DC, Resnick HE, Ruotolo G, Howard BV, Strong Heart Study Investigators. Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study. Diabet Med. 2006 Oct; 23(10):1158-9. PMID: 16978385.
      Citations: 3     Fields:    Translation:Humans
    313. Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Curr Med Res Opin. 2006 Oct; 22(10):2041-53. PMID: 17022864.
      Citations: 21     Fields:    Translation:Humans
    314. Davidson MH, Robinson JG. Lipid-lowering effects of statins: a comparative review. Expert Opin Pharmacother. 2006 Sep; 7(13):1701-14. PMID: 16925498.
      Citations: 15     Fields:    Translation:Humans
    315. Reichenberg A, Gross R, Weiser M, Bresnahan M, Silverman J, Harlap S, Rabinowitz J, Shulman C, Malaspina D, Lubin G, Knobler HY, Davidson M, Susser E. Advancing paternal age and autism. Arch Gen Psychiatry. 2006 Sep; 63(9):1026-32. PMID: 16953005.
      Citations: 196     Fields:    Translation:Humans
    316. Robinson JG, Davidson MH. How low to target LDL? Nat Clin Pract Endocrinol Metab. 2006 Aug; 2(8):414-5. PMID: 16932325.
      Citations:    Fields:    Translation:Humans
    317. Robinson JG, Davidson MH. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction. Expert Rev Cardiovasc Ther. 2006 Jul; 4(4):461-76. PMID: 16918265.
      Citations: 12     Fields:    Translation:Humans
    318. Rabinowitz J, Harvey PD, Eerdekens M, Davidson M. Premorbid functioning and treatment response in recent-onset schizophrenia. Br J Psychiatry. 2006 Jul; 189:31-5. PMID: 16816303.
      Citations: 20     Fields:    Translation:Humans
    319. Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophr Res. 2006 Jul; 85(1-3):254-65. PMID: 16797162.
      Citations: 30     Fields:    Translation:Humans
    320. Davidson MH, Bays HE, Stein E, Maki KC, Shalwitz RA, Doyle R, TRIMS Investigators. Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects. Clin Cardiol. 2006 Jun; 29(6):268-73. PMID: 16796078; PMCID: PMC6653967.
      Citations: 10     Fields:    Translation:Humans
    321. Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials. Clin Ther. 2006 Jun; 28(6):849-59. PMID: 16860168.
      Citations: 3     Fields:    Translation:Humans
    322. Davidson MB, Mehta AE, Siraj ES. Inhaled human insulin: an inspiration for patients with diabetes mellitus? Cleve Clin J Med. 2006 Jun; 73(6):569-78. PMID: 16784157.
      Citations:    Fields:    Translation:Humans
    323. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol. 2006 Aug 21; 98(4A):27i-33i. PMID: 16919514.
      Citations: 96     Fields:    Translation:HumansAnimalsCells
    324. Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M. Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study. Schizophr Res. 2006 Jul; 85(1-3):49-57. PMID: 16626941.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    325. Clark LT, Maki KC, Galant R, Maron DJ, Pearson TA, Davidson MH. Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. J Gen Intern Med. 2006 Apr; 21(4):320-6. PMID: 16686806; PMCID: PMC1484721.
      Citations: 8     Fields:    Translation:Humans
    326. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM, ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med. 2006 Mar 23; 354(12):1253-63. PMID: 16554527.
      Citations: 90     Fields:    Translation:HumansCTClinical Trials
    327. Maki KC, Davidson MH, Dicklin MR. A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey. Can J Cardiol. 2006 Mar 15; 22(4):315-22. PMID: 16568156; PMCID: PMC2560524.
      Citations: 4     Fields:    Translation:Humans
    328. Bays HE, Davidson M, Jones MR, Abby SL. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Am J Cardiol. 2006 Apr 15; 97(8):1198-205. PMID: 16616026.
      Citations: 21     Fields:    Translation:Humans
    329. McKenney JM, Davidson MH, Jacobson TA, Guyton JR, National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006 Apr 17; 97(8A):89C-94C. PMID: 16581336.
      Citations: 106     Fields:    Translation:Humans
    330. Davidson MH, Clark JA, Glass LM, Kanumalla A. Statin safety: an appraisal from the adverse event reporting system. Am J Cardiol. 2006 Apr 17; 97(8A):32C-43C. PMID: 16581327.
      Citations: 33     Fields:    Translation:Humans
    331. Reichenberg A, Weiser M, Caspi A, Knobler HY, Lubin G, Harvey PD, Rabinowitz J, Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J Clin Exp Neuropsychol. 2006 Feb; 28(2):193-207. PMID: 16484093.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    332. Cziraky MJ, Willey VJ, McKenney JM, Kamat SA, Fisher MD, Guyton JR, Jacobson TA, Davidson MH. Statin safety: an assessment using an administrative claims database. Am J Cardiol. 2006 Apr 17; 97(8A):61C-68C. PMID: 16581331.
      Citations: 37     Fields:    Translation:Humans
    333. Davidson MH. Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions. Expert Opin Drug Saf. 2006 Jan; 5(1):145-56. PMID: 16370963.
      Citations: 13     Fields:    Translation:Humans
    334. Deedwania PC, Maki KC, Dicklin MR, Stone NJ, Ballantyne CM, Davidson MH. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II). J Cardiometab Syndr. 2006; 1(5):295-300. PMID: 17679790.
      Citations: 1     Fields:    Translation:Humans
    335. Davidson MH, Yannicelli HD. New concepts in dyslipidemia in the metabolic syndrome and diabetes. Metab Syndr Relat Disord. 2006; 4(4):299-314. PMID: 18370748.
      Citations: 2     Fields:    
    336. Toth PP, Davidson MH. Cholesterol absorption blockade with ezetimibe. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec; 5(6):455-62. PMID: 16503865.
      Citations: 14     Fields:    Translation:Humans
    337. Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry. 2005 Dec; 62(12):1297-304. PMID: 16330717.
      Citations: 53     Fields:    Translation:Humans
    338. Davidson MH, Maccubbin D, Stepanavage M, Strony J, Musliner T. Striated muscle safety of ezetimibe/simvastatin (Vytorin). Am J Cardiol. 2006 Jan 15; 97(2):223-8. PMID: 16442367.
      Citations: 9     Fields:    Translation:Humans
    339. McKenney JM, Davidson MH, Saponaro J, Thompson PD, Bays HE. Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin. J Cardiovasc Pharmacol. 2005 Nov; 46(5):594-9. PMID: 16220065.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    340. Rabinowitz J, Davidson M, De Deyn PP, Katz I, Brodaty H, Cohen-Mansfield J. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance. Am J Geriatr Psychiatry. 2005 Nov; 13(11):991-8. PMID: 16286443.
      Citations: 33     Fields:    Translation:Humans
    341. Corsini A, Bellosta S, Davidson MH. Pharmacokinetic interactions between statins and fibrates. Am J Cardiol. 2005 Nov 07; 96(9A):44K-49K; discussion 34K-35K. PMID: 16291014.
      Citations: 13     Fields:    Translation:Humans
    342. Maki KC, Galant R, Davidson MH. Non-high-density lipoprotein cholesterol: the forgotten therapeutic target. Am J Cardiol. 2005 Nov 07; 96(9A):59K-64K; discussion 34K-35K. PMID: 16291016.
      Citations: 4     Fields:    Translation:Humans
    343. Harvey PD, Rabinowitz J, Eerdekens M, Davidson M. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry. 2005 Oct; 162(10):1888-95. PMID: 16199835.
      Citations: 52     Fields:    Translation:Humans
    344. Davidson MH. Reducing residual risk for patients on statin therapy: the potential role of combination therapy. Am J Cardiol. 2005 Nov 07; 96(9A):3K-13K; discussion 34K-35K. PMID: 16291008.
      Citations: 21     Fields:    Translation:Humans
    345. Davidson MH. Atorvastatin at 80 mg/d reduced major cardiovascular events more than atorvastatin at 10 mg/d in stable coronary heart disease. ACP J Club. 2005 Sep-Oct; 143(2):38. PMID: 16134912.
      Citations:    Fields:    
    346. Bays H, McKenney J, Davidson M. Torcetrapib/atorvastatin combination therapy. Expert Rev Cardiovasc Ther. 2005 Sep; 3(5):789-820. PMID: 16181026.
      Citations: 2     Fields:    Translation:HumansAnimals
    347. Davidson MH. Management of dyslipidemia in patients with complicated metabolic syndrome. Am J Cardiol. 2005 Aug 22; 96(4A):22E-25E. PMID: 16098839.
      Citations: 2     Fields:    Translation:Humans
    348. Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, Palmieri V, Roman M, Devereux RB, Fabsitz RR, Tracy RP, Robbins D, Davidson M, Ahmed A, Howard BV. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation. 2005 Aug 30; 112(9):1289-95. PMID: 16116058.
      Citations: 37     Fields:    Translation:Humans
    349. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol. 2005 Aug 15; 96(4):556-63. PMID: 16098311.
      Citations: 66     Fields:    Translation:Humans
    350. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation. 2005 Jul 26; 112(4):563-71. PMID: 16009795.
      Citations: 63     Fields:    Translation:Humans
    351. Insull W, Davidson MH, Kulkarni PM, Siddhanti S, Ciaccia AV, Keech CA. Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia. Metabolism. 2005 Jul; 54(7):939-46. PMID: 15988705.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    352. Maki KC, Van Elswyk ME, McCarthy D, Hess SP, Veith PE, Bell M, Subbaiah P, Davidson MH. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J Am Coll Nutr. 2005 Jun; 24(3):189-99. PMID: 15930485.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    353. Howard BV, Devereux RB, Cole SA, Davidson M, Dyke B, Ebbesson SO, Epstein SE, Robinson DR, Jarvis B, Kaufman DJ, Laston S, MacCluer JW, Okin PM, Roman MJ, Romenesko T, Ruotolo G, Swenson M, Wenger CR, Williams-Blangero S, Zhu J, Saccheus C, Fabsitz RR, Robbins DC. A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health. 2005 Jun; 64(3):206-21. PMID: 16050315.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    354. Davidson MH, Bays H, Rhyne J, Stein E, Rotenberg K, Doyle R. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2005 Jun; 27(6):715-27. PMID: 16117978.
      Citations: 2     Fields:    Translation:Humans
    355. Malaspina D, Reichenberg A, Weiser M, Fennig S, Davidson M, Harlap S, Wolitzky R, Rabinowitz J, Susser E, Knobler HY. Paternal age and intelligence: implications for age-related genomic changes in male germ cells. Psychiatr Genet. 2005 Jun; 15(2):117-25. PMID: 15900226.
      Citations: 58     Fields:    Translation:HumansCells
    356. Davidson MH. Clinical significance of statin pleiotropic effects: hypotheses versus evidence. Circulation. 2005 May 10; 111(18):2280-1. PMID: 15883224.
      Citations: 18     Fields:    Translation:Humans
    357. Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G, Early Psychosis Global Working Group. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry. 2005 May; 162(5):947-53. PMID: 15863797.
      Citations: 84     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    358. Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J, Purohit DP, Perl DP, Davidson M, Mohs RC, Haroutunian V. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci. 2005 Apr; 60(4):471-5. PMID: 15933386; PMCID: PMC3163091.
      Citations: 87     Fields:    Translation:HumansCells
    359. Beeri MS, Davidson M, Silverman JM, Noy S, Schmeidler J, Goldbourt U. Relationship between body height and dementia. Am J Geriatr Psychiatry. 2005 Feb; 13(2):116-23. PMID: 15703320; PMCID: PMC3163094.
      Citations: 29     Fields:    Translation:Humans
    360. Davidson MH. High-dose statins in acute coronary syndromes. JAMA. 2005 Jan 05; 293(1):38; author reply 38-9. PMID: 15632331.
      Citations:    Fields:    Translation:Humans
    361. Davidson M. Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation. Prev Cardiol. 2005; 8(4):244-9. PMID: 16230879.
      Citations: 4     Fields:    Translation:Humans
    362. Jones PH, Davidson MH. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol. 2005 Jan 01; 95(1):120-2. PMID: 15619408.
      Citations: 78     Fields:    Translation:Humans
    363. Davidson MB, Vidt DG, Hoogwerf BJ, Brotman DJ. Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus. Am J Cardiol. 2005 Jan 01; 95(1):123-6. PMID: 15619409.
      Citations: 5     Fields:    Translation:Humans
    364. Toth PP, Davidson MH. Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin Pharmacother. 2005 Jan; 6(1):131-9. PMID: 15709890.
      Citations: 7     Fields:    Translation:Humans
    365. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004 Nov 23; 63(10):1902-7. PMID: 15557509.
      Citations: 97     Fields:    Translation:Humans
    366. Davidson MH. Rosuvastatin safety: lessons from the FDA review and post-approval surveillance. Expert Opin Drug Saf. 2004 Nov; 3(6):547-57. PMID: 15500414.
      Citations: 22     Fields:    Translation:Humans
    367. Weiser M, Knobler H, Lubin G, Nahon D, Kravitz E, Caspi A, Noy S, Knobler HY, Davidson M. Body mass index and future schizophrenia in Israeli male adolescents. J Clin Psychiatry. 2004 Nov; 65(11):1546-9. PMID: 15554770.
      Citations: 6     Fields:    Translation:Humans
    368. Subbaiah PV, Sowa JM, Davidson MH. Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans. J Lipid Res. 2004 Dec; 45(12):2245-51. PMID: 15466370.
      Citations: 11     Fields:    Translation:Humans
    369. Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Davidson M, Eerdekens M. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder. Int J Geriatr Psychiatry. 2004 Sep; 19(9):898-905. PMID: 15352149.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    370. Davidson MH, Toth PP. Comparative effects of lipid-lowering therapies. Prog Cardiovasc Dis. 2004 Sep-Oct; 47(2):73-104. PMID: 15586350.
      Citations: 30     Fields:    Translation:Humans
    371. Davidson MH. Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management. Postgrad Med. 2004 Sep; 116(3 Suppl):7-12. PMID: 19667670.
      Citations:    Fields:    Translation:Humans
    372. Deedwania PC, Davidson MH, Ballantyne CM. Treating dyslipidemia in high-risk patients: case reviews and discussion. Postgrad Med. 2004 Sep; 116(3 Suppl):21-8. PMID: 19667672.
      Citations:    Fields:    Translation:Humans
    373. Freda BJ, Davidson MB, Hall PM. Evaluation of hyponatremia: a little physiology goes a long way. Cleve Clin J Med. 2004 Aug; 71(8):639-50. PMID: 15449759.
      Citations: 7     Fields:    Translation:Humans
    374. Davidson MH, Toth PP. Combination therapy in the management of complex dyslipidemias. Curr Opin Lipidol. 2004 Aug; 15(4):423-31. PMID: 15243215.
      Citations: 4     Fields:    Translation:Humans
    375. Davidson MH, Ballantyne CM, Kerzner B, Melani L, Sager PT, Lipka L, Strony J, Suresh R, Veltri E, Ezetimibe Study Group. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract. 2004 Aug; 58(8):746-55. PMID: 15372846.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    376. Toth PP, Davidson MH. Therapeutic interventions targeted at the augmentation of reverse cholesterol transport. Curr Opin Cardiol. 2004 Jul; 19(4):374-9. PMID: 15218399.
      Citations: 3     Fields:    Translation:Humans
    377. Weiser M, Reichenberg A, Grotto I, Yasvitzky R, Rabinowitz J, Lubin G, Nahon D, Knobler HY, Davidson M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry. 2004 Jul; 161(7):1219-23. PMID: 15229054.
      Citations: 52     Fields:    Translation:Humans
    378. Davidson MH. Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome. Am J Cardiol. 2004 Jun 03; 93(11A):3C-11C. PMID: 15178511.
      Citations: 6     Fields:    Translation:Humans
    379. Davidoff AJ, Mason MM, Davidson MB, Carmody MW, Hintz KK, Wold LE, Podolin DA, Ren J. Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab. 2004 May; 286(5):E718-24. PMID: 15102617.
      Citations: 22     Fields:    Translation:AnimalsCells
    380. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med. 2004 Apr 15; 116(8):546-54. PMID: 15063817.
      Citations: 67     Fields:    Translation:Humans
    381. Macioch JE, Katsamakis CD, Robin J, Liebson PR, Meyer PM, Geohas C, Raichlen JS, Davidson MH, Feinstein SB. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med. 2004 Feb; 9(1):7-12. PMID: 15230482.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    382. Best LG, Davidson M, North KE, MacCluer JW, Zhang Y, Lee ET, Howard BV, DeCroo S, Ferrell RE. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation. 2004 Feb 03; 109(4):471-5. PMID: 14732744.
      Citations: 29     Fields:    Translation:Humans
    383. Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry. 2004; 65 Suppl 7:4-18; quiz 19-20. PMID: 15151456.
      Citations: 60     Fields:    Translation:Humans
    384. Davidson MH. Biologic therapies for dyslipidemia. Curr Atheroscler Rep. 2004 Jan; 6(1):69-72. PMID: 14662110.
      Citations: 3     Fields:    Translation:Humans
    385. Adunsky A, Chesnin V, Ravona R, Harats D, Davidson M. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study. Arch Gerontol Geriatr. 2004 Jan-Feb; 38(1):61-8. PMID: 14599705.
      Citations: 3     Fields:    Translation:Humans
    386. Schumacher C, Davidson M, Ehrsam G. Cardiovascular disease among Alaska Natives: a review of the literature. Int J Circumpolar Health. 2003 Dec; 62(4):343-62. PMID: 14964763.
      Citations: 23     Fields:    Translation:Humans
    387. Ravona-Springer R, Davidson M, Noy S. The role of cardiovascular risk factors in Alzheimer's disease. CNS Spectr. 2003 Nov; 8(11):824-33. PMID: 14702005.
      Citations: 8     Fields:    Translation:Humans
    388. Davidson MH, Palmisano J, Wilson H, Liss C, Dicklin MR. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d. Clin Ther. 2003 Nov; 25(11):2738-53. PMID: 14693301.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    389. Ballantyne CM, Blazing MA, Hunninghake DB, Davidson MH, Yuan Z, DeLucca P, Ramsey KE, Hustad CM, Palmisano J. Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS). Am Heart J. 2003 Nov; 146(5):862-9. PMID: 14597936.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    390. Davidson MH, Ose L, Frohlich J, Scott RS, Dujovne CA, Escobar ID, Bertolami MC, Cihon F, Maccubbin DL, Mercuri M. Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups. Clin Cardiol. 2003 Nov; 26(11):509-14. PMID: 14640465; PMCID: PMC6653971.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    391. Davidson MH. Newer pharmaceutical agents to treat lipid disorders. Curr Cardiol Rep. 2003 Nov; 5(6):463-9. PMID: 14558988.
      Citations: 2     Fields:    Translation:Humans
    392. Ballantyne CM, Davidson MH. Possible differences between fibrates in pharmacokinetic interactions with statins. Arch Intern Med. 2003 Oct 27; 163(19):2394-5. PMID: 14581261.
      Citations: 4     Fields:    Translation:Humans
    393. Maki KC, Van Elswyk ME, McCarthy D, Seeley MA, Veith PE, Hess SP, Ingram KA, Halvorson JJ, Calaguas EM, Davidson MH. Lipid responses in mildly hypertriglyceridemic men and women to consumption of docosahexaenoic acid-enriched eggs. Int J Vitam Nutr Res. 2003 Oct; 73(5):357-68. PMID: 14639800.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    394. Davidson MH. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events. Curr Atheroscler Rep. 2003 Sep; 5(5):418-22. PMID: 12911853.
      Citations: 1     Fields:    Translation:Humans
    395. Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, Rosenfeld J, Shefner JM, Strong MJ, Sufit R, Anderson FA, ALS CARE Study Group. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep; 4(3):177-85. PMID: 13129795.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    396. Davidson MH. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia. J Am Coll Cardiol. 2003 Jul 16; 42(2):398-9; author reply 399. PMID: 12875794.
      Citations: 1     Fields:    Translation:Humans
    397. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003 Jul 15; 92(2):152-60. PMID: 12860216.
      Citations: 297     Fields:    Translation:HumansCTClinical Trials
    398. Nash IS, Mosca L, Blumenthal RS, Davidson MH, Smith SC, Pasternak RC. Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey. Arch Intern Med. 2003 Jul 14; 163(13):1597-600. PMID: 12860584.
      Citations: 13     Fields:    Translation:Humans
    399. Davidson MH, Maki K, Umporowicz D, Wheeler A, Rittershaus C, Ryan U. The safety and immunogenicity of a CETP vaccine in healthy adults. Atherosclerosis. 2003 Jul; 169(1):113-20. PMID: 12860257.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    400. Davidson MH. Combination lipid-lowering therapy in diabetes. Curr Diab Rep. 2003 Jun; 3(3):263-8. PMID: 12762976.
      Citations:    Fields:    Translation:Humans
    401. Davidson MH. Ezetimibe: a novel option for lowering cholesterol. Expert Rev Cardiovasc Ther. 2003 May; 1(1):11-21. PMID: 15030293.
      Citations: 11     Fields:    Translation:Humans
    402. Beeri MS, Werner P, Davidson M, Schmidler J, Silverman J. Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew. Int J Geriatr Psychiatry. 2003 May; 18(5):381-6. PMID: 12766912.
      Citations: 27     Fields:    Translation:Humans
    403. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, Reckless JP, Stein EA, März W. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003 Mar 10; 163(5):553-64. PMID: 12622602.
      Citations: 92     Fields:    Translation:Humans
    404. Rader DJ, Davidson MH, Caplan RJ, Pears JS. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. Am J Cardiol. 2003 Mar 06; 91(5A):20C-23C; discussion 23C-24C. PMID: 12646340.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    405. Maki KC, Shinnick F, Seeley MA, Veith PE, Quinn LC, Hallissey PJ, Temer A, Davidson MH. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr. 2003 Mar; 133(3):808-13. PMID: 12612157.
      Citations: 7     Fields:    Translation:HumansAnimalsCTClinical Trials
    406. Rabinowitz J, Shlezinger T, Khatib A, Davidson M. Perceived patient threat and neuroleptic dosage. J Nerv Ment Dis. 2003 Feb; 191(2):129-30. PMID: 12586969.
      Citations:    Fields:    Translation:Humans
    407. Davidson MH, Geohas CT. Efficacy of over-the-counter nutritional supplements. Curr Atheroscler Rep. 2003 Jan; 5(1):15-21. PMID: 12562537.
      Citations:    Fields:    Translation:Humans
    408. Isaacsohn J, Hunninghake D, Schrott H, Dujovne CA, Knopp R, Weiss SR, Bays H, Crouse JR, Davidson MH, Keilson LM, McKenney J, Korenman SG, Dobs AS, Stein E, Krauss RM, Maccubbin D, Cho M, Plotkin DJ, Mitchel YB. Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol. 2003 Jan; 26(1):18-24. PMID: 12539808; PMCID: PMC6654219.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    409. Braun LT, Davidson MH. Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal. J Cardiovasc Nurs. 2003 Jan-Mar; 18(1):44-9; quiz 75-6. PMID: 12537089.
      Citations: 2     Fields:    Translation:Humans
    410. Blesa R, Davidson M, Kurz A, Reichman W, van Baelen B, Schwalen S. Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months. Dement Geriatr Cogn Disord. 2003; 15(2):79-87. PMID: 12566596.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    411. Davidson MH, Kurlandsky SB, Kleinpell RM, Maki KC. Lipid management and the elderly. Prev Cardiol. 2003; 6(3):128-33; quiz 134-5. PMID: 15319582.
      Citations: 1     Fields:    Translation:Humans
    412. Davidson MH, McGarry T, Bettis R, Melani L, Lipka LJ, LeBeaut AP, Suresh R, Sun S, Veltri EP. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol. 2002 Dec 18; 40(12):2125-34. PMID: 12505224.
      Citations: 100     Fields:    Translation:HumansCTClinical Trials
    413. Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A, Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002 Dec 03; 137(11):875-83. PMID: 12458987.
      Citations: 48     Fields:    Translation:HumansCTClinical Trials
    414. Maki KC, Davidson MH, Tsushima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, Anderson BD, Frost SD, Bell M, Maki KC, Davidson MH, Tsushima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, Anderson BD, Frost SD, Bell M. Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. Am J Clin Nutr. 2002 Dec; 76(6):1230-6. PMID: 12450887.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    415. Rabinowitz J, De Smedt G, Harvey PD, Davidson M, Rabinowitz J, De Smedt G, Harvey PD, Davidson M. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. Am J Psychiatry. 2002 Dec; 159(12):2021-6. PMID: 12450951.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    416. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, Davidson M, Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, Davidson M. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry. 2002 Dec; 159(12):2027-35. PMID: 12450952.
      Citations: 88     Fields:    Translation:HumansPHPublic Health
    417. Davidson MH. Combination therapy for dyslipidemia: safety and regulatory considerations. Am J Cardiol. 2002 Nov 20; 90(10B):50K-60K. PMID: 12467940.
      Citations: 16     Fields:    Translation:Humans
    418. Adunsky A, Chesnin V, Davidson M, Gerber Y, Alexander K, Haratz D, Adunsky A, Chesnin V, Davidson M, Gerber Y, Alexander K, Haratz D. A cross-sectional study of lipids and ApoC levels in Alzheimer's patients with and without cardiovascular disease. J Gerontol A Biol Sci Med Sci. 2002 Nov; 57(11):M757-61. PMID: 12403806.
      Citations: 1     Fields:    Translation:Humans
    419. Davidson MH. Controversy surrounding the safety of cerivastatin. Expert Opin Drug Saf. 2002 Sep; 1(3):207-12. PMID: 12904136.
      Citations: 12     Fields:    Translation:Humans
    420. Davidson M, Min YI, Holbrook JT, Van Natta M, Quinn TC, Murphy RL, Welch W, Jabs DA, Meinert CL, Studies of Ocular Complications of AIDS Research Group. Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. J Infect Dis. 2002 Oct 01; 186(7):1013-8. PMID: 12232843.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    421. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002 Jul 03; 288(1):49-57. PMID: 12090862.
      Citations: 278     Fields:    Translation:HumansCTClinical Trials
    422. Davidson MH, Davidson MH, National cholesterol Education Program (NCEP) Adult Treatment Panel (ATP)--ATP III Guidelines. A look to the future: new treatment guidelines and a perspective on statins. Am J Med. 2002 Jun 03; 112 Suppl 8A:34S-41S. PMID: 12049993.
      Citations: 3     Fields:    Translation:Humans
    423. Beeri MS, Werner P, Adar Z, Davidson M, Noy S. Economic cost of Alzheimer disease in Israel. Alzheimer Dis Assoc Disord. 2002 Apr-Jun; 16(2):73-80. PMID: 12040302.
      Citations: 10     Fields:    Translation:Humans
    424. Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL, Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL, Studies of Ocular Complications of AIDS Research Group. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. AIDS. 2002 Mar 29; 16(5):757-65. PMID: 11964532.
      Citations:    Fields:    Translation:Humans
    425. Davidson MH. A symposium: National Cholesterol Education Program Adult Treatment Panel III: Impact and implementation of the new guidelines. Introduction. Am J Cardiol. 2002 Mar 07; 89(5A):1C-2C. PMID: 11900711.
      Citations: 5     Fields:    Translation:Humans
    426. Davidson MH. Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance. Am J Cardiol. 2002 Mar 07; 89(5A):8C-20C; discussion 20C-22C. PMID: 11900713.
      Citations: 5     Fields:    Translation:Humans
    427. Davidson MH. Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia. Expert Opin Investig Drugs. 2002 Mar; 11(3):125-41. PMID: 12769127.
      Citations: 2     Fields:    Translation:Humans
    428. Furberg CD, Vittinghoff E, Davidson M, Herrington DM, Simon JA, Wenger NK, Hulley S. Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. Circulation. 2002 Feb 26; 105(8):917-22. PMID: 11864918.
      Citations: 9     Fields:    Translation:HumansAnimals
    429. Davidson M, Ma P, Stein EA, Gotto AM, Raza A, Chitra R, Hutchinson H. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. Am J Cardiol. 2002 Feb 01; 89(3):268-75. PMID: 11809427.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    430. Davidson MH. Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia. Expert Opin Investig Drugs. 2002 Jan; 11(1):125-41. PMID: 11772327.
      Citations: 20     Fields:    Translation:Humans
    431. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry. 2002; 63 Suppl 9:5-11. PMID: 12088174.
      Citations: 23     Fields:    Translation:Humans
    432. Davidson MH, Lukacsko P, Sun JX, Phillips G, Walters E, Sterman A, Niecestro R, Friedhoff L, Davidson MH, Lukacsko P, Sun JX, Phillips G, Walters E, Sterman A, Niecestro R, Friedhoff L. A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin. Clin Ther. 2002 Jan; 24(1):112-25. PMID: 11833826.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    433. Davidson MH, Maki KC, Karp SK, Ingram KA. Management of hypercholesterolaemia in postmenopausal women. Drugs Aging. 2002; 19(3):169-78. PMID: 12027776.
      Citations: 12     Fields:    Translation:Humans
    434. Meltzer HY, Davidson M, Glassman AH, Vieweg WV. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J Clin Psychiatry. 2002; 63 Suppl 9:25-9. PMID: 12088173.
      Citations: 10     Fields:    Translation:Humans
    435. Johnson JV, Davidson M, Archer D, Bachmann G. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause. 2002 Jan-Feb; 9(1):16-22. PMID: 11791082.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    436. Insull W, Toth P, Mullican W, Hunninghake D, Burke S, Donovan JM, Davidson MH. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Mayo Clin Proc. 2001 Oct; 76(10):971-82. PMID: 11605698.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    437. Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, Nahon D, Davidson M, Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, Nahon D, Davidson M. Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry. 2001 Oct; 58(10):959-64. PMID: 11576035.
      Citations: 13     Fields:    Translation:Humans
    438. Hunninghake D, Insull W, Knopp R, Davidson M, Lohrbauer L, Jones P, Kafonek S. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia. Am J Cardiol. 2001 Sep 15; 88(6):635-9. PMID: 11564386.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    439. Davidson MH, Maki KC, Umporowicz DM, Ingram KA, Dicklin MR, Schaefer E, Lane RW, McNamara JR, Ribaya-Mercado JD, Perrone G, Robins SJ, Franke WC, Davidson MH, Maki KC, Umporowicz DM, Ingram KA, Dicklin MR, Schaefer E, Lane RW, McNamara JR, Ribaya-Mercado JD, Perrone G, Robins SJ, Franke WC. Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr. 2001 Aug; 20(4):307-19. PMID: 11506058.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    440. Davidson MH, Davidson MH. Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions. J Cardiovasc Pharmacol Ther. 2001 Jul; 6(3):219-29. PMID: 11584328.
      Citations: 1     Fields:    Translation:Humans
    441. Insull W, Koren M, Davignon J, Sprecher D, Schrott H, Keilson LM, Brown AS, Dujovne CA, Davidson MH, McLain R, Heinonen T. Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis. 2001 Jul; 157(1):137-44. PMID: 11427213.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    442. Maki KC, Davidson MH, Umporowicz DM, Schaefer EJ, Dicklin MR, Ingram KA, Chen S, McNamara JR, Gebhart BW, Ribaya-Mercado JD, Perrone G, Robins SJ, Franke WC. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr. 2001 Jul; 74(1):33-43. PMID: 11451715.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    443. Davidson MH, Toth P, Weiss S, McKenney J, Hunninghake D, Isaacsohn J, Donovan JM, Burke SK, Davidson MH, Toth P, Weiss S, McKenney J, Hunninghake D, Isaacsohn J, Donovan JM, Burke SK. Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Clin Cardiol. 2001 Jun; 24(6):467-74. PMID: 11403509; PMCID: PMC6655189.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    444. Rabinowitz J, Davidson M. Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis. Schizophr Res. 2001 May 30; 50(1-2):89-93. PMID: 11378317.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    445. Raggi P, Callister TQ, Davidson M, Welty FK, Bachmann GA, Laskey R, Pittman D, Kafonek S, Scott R. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial. Am Heart J. 2001 May; 141(5):722-6. PMID: 11320358.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    446. Grey M, Davidson M, Boland EA, Tamborlane WV. Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus. J Adolesc Health. 2001 May; 28(5):377-85. PMID: 11336867.
      Citations: 35     Fields:    Translation:Humans
    447. Harris ST, Eriksen EF, Davidson M, Ettinger MP, Moffett AH, Baylink DJ, Crusan CE, Chines AA. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2001 05; 86(5):1890-7. PMID: 11344179.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    448. Hirano M, Davidson M, DiMauro S. Mitochondria and the heart. Curr Opin Cardiol. 2001 May; 16(3):201-10. PMID: 11357017.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    449. Rabinowitz J, Hornik T, Davidson M. Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial. J Clin Psychiatry. 2001 May; 62(5):343-6. PMID: 11411815.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    450. Knapp HH, Schrott H, Ma P, Knopp R, Chin B, Gaziano JM, Donovan JM, Burke SK, Davidson MH. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Am J Med. 2001 Apr 01; 110(5):352-60. PMID: 11286949.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    451. Bromberg MB, Anderson F, Davidson M, Miller RG. Assessing health status quality of life in ALS: comparison of the SIP/ALS-19 with the ALS Functional Rating Scale and the Short Form-12 Health Survey. ALS C.A.R.E. Study Group. Clinical Assessement, Research, and Education. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Mar; 2(1):31-7. PMID: 11465931.
      Citations: 3     Fields:    Translation:Humans
    452. Davidson MH. Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents. Am J Cardiol. 2001 Feb 16; 87(4A):1A-7A. PMID: 11243600.
      Citations: 3     Fields:    Translation:Humans
    453. Davidson MH. Statin trials in progress: unanswered questions. Curr Atheroscler Rep. 2001 Jan; 3(1):9-13. PMID: 11123842.
      Citations: 1     Fields:    Translation:Humans
    454. Dujovne CA, Bays H, Davidson MH, Knopp R, Hunninghake DB, Stein EA, Goldberg AC, Jones P, Lipka LJ, Cuffie-Jackson C. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study. J Clin Pharmacol. 2001 Jan; 41(1):70-8. PMID: 11144997.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    455. Davidson MH. Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust. Drugs. 2001; 61(2):197-206. PMID: 11270938.
      Citations: 22     Fields:    Translation:Humans
    456. Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Curr Med Res Opin. 2001; 17(1):43-50. PMID: 11464446.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    457. Davidson MH, Dicklin MR, Maki KC, Kleinpell RM, Davidson MH, Dicklin MR, Maki KC, Kleinpell RM. Perspectives: Benefits of a new, nonsystemic lipid-lowering agent: the clinician's perspective. Prev Cardiol. 2001; 4(1):38-39. PMID: 11828197.
      Citations:    Fields:    
    458. Davidson M, Davidson M. Long-term safety of risperidone. J Clin Psychiatry. 2001; 62 Suppl 21:26-8. PMID: 11584985.
      Citations: 1     Fields:    Translation:Humans
    459. Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med. 2000 Nov 27; 160(21):3315-25. PMID: 11088095.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    460. Davidson MH, Dicklin MR, Maki KC, Kleinpell RM. Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent. Expert Opin Investig Drugs. 2000 Nov; 9(11):2663-71. PMID: 11060828.
      Citations: 5     Fields:    Translation:HumansAnimals
    461. Davidson M, Marwah A, Sawchuk RJ, Maki K, Marwah P, Weeks C, Lardy H. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers. Clin Invest Med. 2000 Oct; 23(5):300-10. PMID: 11055323.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    462. Davidson MH, Stein EA, Hunninghake DB, Ose L, Dujovne CA, Insull W, Bertolami M, Weiss SR, Kastelein JJ, Scott RS, Escobar ID, Schrott HG, Bays H, Stepanavage ME, Wu M, Tate AC, Melino MR, Kush D, Mercuri M, Mitchel YB, Davidson MH, Stein EA, Hunninghake DB, Ose L, Dujovne CA, Insull W, Bertolami M, Weiss SR, Kastelein JJ, Scott RS, Escobar ID, Schrott HG, Bays H, Stepanavage ME, Wu M, Tate AC, Melino MR, Kush D, Mercuri M, Mitchel YB, Worldwide Expanded Dose Simvastatin Study Group. Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis. 2000 Oct; 10(5):253-62. PMID: 11213534.
      Citations: 8     Fields:    Translation:Humans
    463. Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism. 2000 Sep; 49(9):1234-8. PMID: 11016911.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    464. Stein E, Plotkin D, Bays H, Davidson M, Dujovne C, Korenman S, Stepanavage M, Mercuri M. Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia. Am J Cardiol. 2000 Aug 15; 86(4):406-11. PMID: 10946033.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    465. Kastelein JJ, Isaacsohn JL, Ose L, Hunninghake DB, Frohlich J, Davidson MH, Habib R, Dujovne CA, Crouse JR, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB. Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. Am J Cardiol. 2000 Jul 15; 86(2):221-3. PMID: 10913488.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    466. Isaacsohn JL, Davidson MH, Hunninghake D, Singer R, McLain R, Black DM. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease. Am J Cardiol. 2000 Jul 15; 86(2):250-2. PMID: 10913499.
      Citations: 3     Fields:    Translation:Humans
    467. Maki KC, Davidson MH, Torri S, Ingram KA, O'Mullane J, Daggy BP, Albrecht HH. High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men. J Nutr. 2000 Jul; 130(7):1705-10. PMID: 10867040.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    468. Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000 Jul; 137(1):107-13. PMID: 10891831.
      Citations: 129     Fields:    Translation:HumansCTClinical Trials
    469. Perdue DG, Bulkow LR, Gellin BG, Davidson M, Petersen KM, Singleton RJ, Parkinson AJ. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA. 2000 Jun 21; 283(23):3089-94. PMID: 10865303.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    470. Siscovick D, Alexander R, Davidson M, Leinonen M, O'Connor S, Ewald P, Meier C, Puolakkainen M, Hughes J, Nieto J. Collaborative multidisciplinary workshop report: the role of epidemiology studies in determining a possible relationship between Chlamydia pneumoniae infection and atherothrombotic diseases. J Infect Dis. 2000 Jun; 181 Suppl 3:S430-1. PMID: 10839730.
      Citations:    Fields:    Translation:HumansCells
    471. Hunninghake DB, Maki KC, Kwiterovich PO, Davidson MH, Dicklin MR, Kafonek SD. Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia. J Am Coll Nutr. 2000 Jun; 19(3):351-60. PMID: 10872897.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    472. Davidson M, Harvey PD, Vervarcke J, Gagiano CA, De Hooge JD, Bray G, Dose M, Barak Y, Haushofer M. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. Int J Geriatr Psychiatry. 2000 Jun; 15(6):506-14. PMID: 10861916.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    473. Anderson JW, Davidson MH, Blonde L, Brown WV, Howard WJ, Ginsberg H, Allgood LD, Weingand KW. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr. 2000 Jun; 71(6):1433-8. PMID: 10837282.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    474. Davidson MH. Efficacy of antiobesity therapies. Am J Clin Nutr. 2000 Mar; 71(3):844. PMID: 10702183.
      Citations:    Fields:    Translation:Humans
    475. Maki KC, Davidson MH, Marx P, Cyrowski MS, Maki A. Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women. Am J Cardiol. 2000 Feb 15; 85(4):451-6. PMID: 10728949.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    476. Maki KC, Davidson MH, Cyrowski MS, Maki AC, Marx P. Low-density lipoprotein subclass distribution pattern and adiposity-associated dyslipidemia in postmenopausal women. J Am Coll Nutr. 2000 Feb; 19(1):23-30. PMID: 10682872.
      Citations: 2     Fields:    Translation:Humans
    477. Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW, Emkey R, Meunier PJ, Miller SS, Mulloy AL, Recker RR, Weiss SR, Heyden N, Musliner T, Suryawanshi S, Yates AJ, Lombardi A. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab. 2000 Feb; 85(2):720-6. PMID: 10690882.
      Citations: 49     Fields:    Translation:HumansAnimalsCTClinical Trials
    478. Munshi M, Davidson M, MacDonald PB, Froese W, Sutherland K. The efficacy of magnetic resonance imaging in acute knee injuries. Clin J Sport Med. 2000 Jan; 10(1):34-9. PMID: 10695848.
      Citations: 20     Fields:    Translation:Humans
    479. Davidson MH. Does differing metabolism by cytochrome p450 have clinical importance? Curr Atheroscler Rep. 2000 Jan; 2(1):14-9. PMID: 11122720.
      Citations: 10     Fields:    Translation:Humans
    480. Ose L, Davidson MH, Stein EA, Kastelein JJ, Scott RS, Hunninghake DB, Campodonico S, Insull W, Escobar ID, Schrott HG, Stepanavage ME, Wu M, Tate AC, Melino MR, Mercuri M, Mitchel YB. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol. 2000 Jan; 23(1):39-46. PMID: 10680028; PMCID: PMC6654890.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    481. Klock SC, Stout JE, Davidson M. Analysis of Minnesota Multiphasic Personality Inventory-2 profiles of prospective anonymous oocyte donors in relation to the outcome of the donor selection process. Fertil Steril. 1999 Dec; 72(6):1066-72. PMID: 10593383.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    482. Abraham R, Chen C, Tsang R, Simpson D, Murray C, Davidson M, Meharchand J, Sutton DM, Crump RM, Keating A, Stewart AK. Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma. Bone Marrow Transplant. 1999 Dec; 24(12):1291-7. PMID: 10627637.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    483. Maki KC, Davidson MH, Malik KC, Albrecht HH, O'Mullane J, Daggy BP. Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose. Am J Cardiol. 1999 Nov 15; 84(10):1198-203. PMID: 10569330.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    484. Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, Nides MA, Davidson M. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health. 1999 Nov; 89(11):1701-7. PMID: 10553392; PMCID: PMC1508975.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    485. Davidson MH, Dillon MA, Gordon B, Jones P, Samuels J, Weiss S, Isaacsohn J, Toth P, Burke SK. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med. 1999 Sep 13; 159(16):1893-900. PMID: 10493319.
      Citations: 57     Fields:    Transl